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11Introduction
Quality improvement in healthcare
Quality of healthcare is difficult to define and multi-interpretable. A commonly used definition 
is from the Institute of Medicine (IoM):”Quality of care is the degree to which health services 
for individuals and populations increase the likelihood of desired outcomes and are consistent 
with current professional knowledge” (1). This definition shows that quality of care does not 
only concern direct patient care but also depends on conditions that are needed to provide 
care. A practical interpretation was given by Donabedian by describing quality in relation to 
structure, process and outcomes (2).  Structure measures include the availability of resources, 
management systems and policy guidelines. It is regarded as the basis of a hospital organization. 
Process measures represent the processes necessary for day-to-day healthcare delivery. 
Outcomes are the ‘end-results’ and can contain medical indicators (e.g. mortality, complication 
rates) as well as patient satisfaction data. Donabedian’s model assumes a dynamic relationship 
between the three components based on the logical assumption that good outcomes rely on 
good processes, which rely on good structure. 
Improving the quality of care is frequently described  by the concept of continuous quality 
improvement (CQI).  CQI is originally an industrial model of quality improvement that has 
proven its value in several manufacturing situations and organizations especially in Japan. It 
entails enlisting an entire organization to work towards a goal of continuous improvement in 
quality as defined by the needs and wants of the customer. This model gained popularity on its 
appliance in hospitals in the early 1990’s. Measurement of quality plays an important role in 
CQI and the Deming cycle, or Plan-Do-Check-Act cycle, is often incorporated in the bigger 
concept of CQI. It consists of a cyclic four-stage learning approach; in the ‘plan’ stage the aims 
of improvement are identified, the ‘do’ stage is the actual execution of change, the ‘check’ stage 
examines the success of the change and the ‘act’ stage identifies adaptations and next steps to 
inform a new cycle. In later years the ‘check’ stage has been referred to as ‘study’ stage because 
‘check’ emphasizes inspection over analysis.  The combination of the Deming cycle and the 
concept of continuous quality improvement results in an ideal situation in which the quality-
level gets higher and higher over time as can be seen in Figure 1.
plan do
act check
plan do
checkact
Quality
Figure 1. The Deming cycle in relation to 
continuous quality improvement.
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External peer review
The  success of quality improvement programmes relies for an important part on (social) context 
(3). Effective interventions need to be complex and multifaceted and developed iteratively to 
adapt to the local context and respond to unforeseen obstacles and unintended effects (4). 
In the Netherlands, external peer review (in Dutch: visitatie) is a cornerstone in evaluating 
and improving the quality of healthcare. It has been identified by The External Peer Review 
Techniques (ExPErT) programme as one of four main methods used in Europe in this field 
together with accreditation, International Standardisation Organization (ISO) certification, and 
the European Foundation of Quality Management (EFQM) excellence model (5, 6).  In general, 
external peer review and accreditation are the closest to the actual delivery of healthcare, 
whereas ISO certification and the EFQM excellence model focus primarily on the managerial 
and organizational conditions under which care processes are executed (7). Common grounds 
are shared between accreditation and external peer review; the most important differences are 
the collegial approach in external peer review, confidentiality of reports and often the absence 
of an award or certificate in external peer review. The incentives for both methods can be similar 
but accreditation mostly has a more regulatory compulsive character while external peer review 
is often improvement driven and voluntary. Internationally, accreditation is the most frequently 
used method for quality evaluation. Table 1 highlights the main features and differences of 
accreditation and external peer review.
External peer review Accreditation
Origins The Netherlands, as part of quality assurance of 
specialist training programmes
USA, 1917 Hospital Standardization programme set 
up by American College of Surgeons
Surveyors Peers being practicing professionals Healthcare professionals
Preparations Self-review addressing the organisational and 
procedural aspects of 
professional performance
Self-review stating the compliance to a set of 
explicit standards
Evaluation Visit by external peer review committee 
addressing key issues of the self-review
On-site observation
On-site interviews
Grading compliance to standards using self-review 
On-site observation
On-site interviews
Report Description of the organization, positive and 
negative findings, recommendations for im-
provement and comparisons with standards
Compliance and non-compliance with standards of 
the accreditation programme
Certification None Yes, accreditation
Disclosure Confidential Public
Table 1. Key features and differences of external peer review and accreditation (6, 8).
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There is limited evidence on the effectiveness of external peer review in the Netherlands. 
Lombarts and Klazinga published an extensive paper on the introduction and development of 
external peer review. They state that many stakeholders perceived it as a credible instrument for 
assuring the quality of care. Besides, it plays an important role in the positioning of the medical 
profession as a reliable partner in delivering healthcare (9). Another study by these authors 
showed that external peer review seems to enforce the development of management of medical 
care (10). A study on peer review amongst general practitioners found significant improvements 
on many aspects of practice management, such as equipment, record keeping, organization of 
information and delegation (11). Descriptive studies were published on external peer review of 
paediatric care in the Netherlands and on the legal perspectives (12, 13).  
Few international studies have been published on the effects on clinical outcomes. Roberts et al 
report on the one- and three-year evaluation of peer review for chronic obstructive pulmonary 
disease in the United Kingdom (14, 15). Their findings after three years indicated an association 
with improved quality of care, service delivery and changes that promote (and are precursors 
to) quality improvement. Their one-year evaluation showed no significant differences leading 
to the conclusion that changes can take a prolonged period to occur. In lung cancer care, peer 
review was successful in stimulating quality improvement activities but improvements in 
treatment rates and patient experiences were small (16). More research has been done on the 
impact of accreditation programmes on the quality of care. Two recent systematic reviews on 
accreditation revealed complicated relationships and the authors were hesitant to make strong 
claims about the effects due to limitations of the studies (17, 18). 
External peer review for multidisciplinary cancer care in the 
Netherlands
During the 1980s and 90s, cancer treatment became increasingly multidisciplinary. Adjuvant 
chemotherapy and radiotherapy transferred cancer treatment from a monodisciplinary 
responsibility to the responsibility of multiple medical specialties. Multidisciplinary care was 
promoted by the Comprehensive Cancer Organizations. Before their fusion into one national 
organization in 2011 there were eight regional Comprehensive Cancer Organizations. They 
formed networks of healthcare professionals and cancer institutes aiming to improve cancer 
care through cancer registry, research, guideline development, knowledge exchange and 
organizational improvement without having a treatment function themselves. Anticipating 
the increasing multidisciplinary treatment of cancer patients, the Comprehensive Cancer 
Organization in the North of the Netherlands introduced an external peer review programme 
in 1994 to review the multidisciplinary organization of cancer care in hospitals. The programme 
gradually spread over the country and was eventually used nationwide. A majority of Dutch 
hospitals has gone through the procedure at least once and in some regions already thrice. 
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The programme initially focussed on organizational requirements for multidisciplinary 
care. Over time, it evolved and also paid attention to important (inter)national trends such 
as centralization. However, the primary focus remained on the organization of cancer care as 
a whole (not specific tumour types). Participation is voluntary and there is no certification 
afterwards. Findings are documented in a confidential report.
The programme relies on a pre-established quality framework and hospital organizations and 
processes are compared to the standards of this framework. The quality framework evolves 
around nine focus areas of which there are five organizational areas and four result areas. The 
framework is based on the INK (Instituut Nederlandse Kwaliteit) management model (Figure 
2). For each focus area, standards and requirements are defined by medical specialists and 
healthcare professionals.
Leadership
Sta 
management
Strategy and 
policy
Resources 
management
Process 
management
Patient and 
partner 
satisfaction
Outcomes and 
transparancy
Organization Results
Continuous improvement
Employee 
satisfaction
Community
satisfaction
Figure 2. Focus areas of the quality framework of the external peer review programme for 
multidisciplinary cancer care. 
 
When a hospital applies to participate in the programme they start with an extensive self-
review. The actual site-visit combined with the self-review serves as a mirror, reflecting the 
weak and strong points of the organization. Participation in the programme gives insight in 
which areas improvement is needed and recommendations for improvement are given. Major 
topics of recommendations were the organization of weekly multidisciplinary patient care 
meetings, shared decision making between specialists, oncological specialization of medical 
specialists, dedication of oncology committees to policy making, introduction of integrated 
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care pathways, referral policies for low volume tumours and highly complicated interventions 
and working according to evidence based guidelines. Figure 3 presents a flow chart of the entire 
peer review process.
Objectives and thesis outline
Even though there is almost 20 years of experience with the external peer review programme 
for multidisciplinary cancer care there is no structured evidence of its effectiveness on quality 
improvement. This is a more general problem for external peer review and accreditation 
programmes. The lack of conclusive evidence has led to many calls for research in the fields 
of external peer review and accreditation (19, 20).  As Ovretveit stated: “Many countries are 
embarking on accreditation programmes without any evidence that they are the best use of 
resources for improving quality and no evidence about the effectiveness of different systems 
and ways to implement them” (21).
This thesis aims to investigate the impact of the external peer review programme for 
multidisciplinary cancer care on clinical outcomes and organization. The following research 
questions will be investigated:
- How can the impact of external peer review on quality of care be studied                     
   methodologically?
- What is the impact of the programme on the clinical quality of cancer care? 
- What are the experiences of stakeholders and what is the perceived value of the programme?
- What drives quality related organizational change in cancer care?
Figure 3. Flow-chart of the external peer review process, hospitals are advised to participate every 
4-5 years.
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Chapter 2 reports on the results of a literature review on research methods used in previous 
studies on the impact of external peer review and accreditation in order to create a general 
research model. As previous research has showed,  research in the field of quality improvement 
through external peer review and accreditation is challenging and difficult. This is partly 
because the programmes are difficult to evaluate: they change over time, are applied to 
changing organizations and need to be assessed from different perspectives (21, 22). Other 
factors such as guidelines and other quality programmes influence patient outcomes as well. 
Most programmes do not directly focus on patient outcomes but on organizations as a whole. 
Therefore, a relationship between patient outcomes and peer review programmes is difficult 
(if not impossible) to prove. Based on the literature in the review a general research model is 
proposed to optimize research designs of studies on external peer review and accreditation.
The impact of the external peer review programme for multidisciplinary care on clinical 
outcomes is studied by evaluating specific multidisciplinary treatment characteristics. Chapter 
3 reports on the impact of implementing the recommendations from the programme on 
colorectal cancer treatment and survival in the Netherlands. Specifically, the paper investigates 
whether (1) the participation in the external peer review programme and (2) the extent of the 
implementation of recommendations impacted multidisciplinary treatment patterns (such as 
combined treatment modalities) and survival of colorectal cancer patients. Colorectal cancer 
was amongst the first types of cancer requiring multidisciplinary treatment. Previous studies 
showed treatment variation that can not be explained by medical factors alone. It is suggested 
that hospital characteristics play a role in explaining this treatment variation (23, 24). Chapter 
4 analyses treatment patterns in breast cancer patients who were treated in hospitals from two 
different regions in the Netherlands and a control group. Comparing different regions creates 
the opportunity to analyse the influence of regional factors as well as the possible external peer 
review influence. Breast cancer is the commonest type of cancer in women in the Netherlands 
and its treatment is marked by a multidisciplinary approach and specialization of the involved 
physicians and nursing staff. 
In Chapter 5 a qualitative study is presented where physicians, nurses and managers reflect 
on their experiences with the programme, the perceived impact and the role of external peer 
review in the future. Telephonic interviews were conducted with 31 stakeholders from 15 
different hospitals. 
Chapter 6 studies the centralization patterns of surgical treatment for pancreas, oesophagus and 
bladder cancer. This provides a more general insight in what drives quality related organizational 
change in cancer care. Centralization of low-volume tumours and highly-complex surgical 
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interventions is the best studied form of quality improvement through organizational change. 
As there are many factors that may have been of influence, we identified whether and which 
professional, organizational and regulatory stimuli were effective in stimulating centralization 
of cancer care. 
In the general discussion (Chapter 7) the future of external peer review in cancer care is 
discussed, incorporating the research results from the previous chapters. 
18 Chapter 1
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Abstract
Purpose
Accreditation and external peer review play important roles in assessing and improving 
healthcare quality worldwide. Evidence on the impact on the quality of care remains indecisive 
because of programme features and methodological research challenges. The purpose of this 
paper is to create a general methodological research framework to design future studies in this 
field. 
Design
A literature search on effects of external peer review and accreditation was conducted using 
Pubmed/Medline, Embase and Web of Science. Three researchers independently screened 
the studies. Only original research papers that studied the impact on the quality of care were 
included. Studies were evaluated by their objectives and outcomes, study size and analysis entity 
(hospitals vs patients), theoretical framework, focus of the studied programme, heterogeneity 
of the study population and presence of a control group.
Findings
After careful selection 50 articles were included out of an initial 2,025 retrieved references. 
Analysis showed a wide variation in methodological characteristics. Most studies are performed 
cross-sectionally and results are not linked to the programme by a theoretical framework. 
Originality/value
Based on the methodological characteristics of previous studies the authors propose a general 
research framework. This framework is intended to support the design of future research to 
evaluate the effects of accreditation and external peer review on the quality of care. 
23
Introduction
External quality assessment programmes play an important role in assessing and improving 
health care quality. The External Peer Review Techniques (ExPErT) programme identified 
four main methods used in Europe in this field: accreditation, International Standardisation 
Organisation (ISO) certification, visitatie/external peer review and the European Foundation 
of Quality Management (EFQM) excellence model (Heaton, 2000). ISO certification and the 
EFQM excellence model focus primarily on the managerial and organisational conditions 
under which care processes are executed. External peer review and accreditation are the closest 
to the actual deliverance of healthcare (Klazinga et al, 2000). Therefore, in this study we focus 
on the last two methods. Important differences between external peer review and accreditation 
are the collegial approach, confidential reports and the absence of an award or certificate in 
external peer review. Incentives for both methods can be similar but accreditation often has 
a regulatory character while external peer review often is improvement driven and voluntary 
(Table 1) (Heaton, 2000; Klazinga et al, 2000). Programme standards are based on evidence- 
based guidelines, theoretical organisational models and expert consensus. Adherence to the 
standards is seen as proxy of how well care is organised.
While designed to assess and improve the organisation and quality of care, the actual impact 
on clinical and organisational outcomes such as guideline adherence or adverse effects 
remains unclear (Shaw, 2001; Greenfield and Braithwaite, 2008; Greenfield and Braithwaite, 
2009; Hinchcliff et al., 2012). Recent literature reviews on accreditation revealed complicated 
relationships and the authors were hesitant to make strong claims about the effects due to 
limitations of the studies (Greenfield and Braithwaite, 2008; Hinchcliff et al., 2012). 
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External peer review Accreditation
Origins The Netherlands, as part of quality assurance 
of specialist training programmes
USA, 1917 Hospital Standardization programme set 
up by American College of Surgeons
Surveyors Peers being practicing professionals Healthcare professionals
Preparations Self-review addressing the organisational 
and procedural aspects of 
professional performance
Self-review stating the compliance to a set of explicit 
standards
Evaluation Visit by external peer review committee 
addressing key issues of self-review
On site observation
On site interviews
Grading compliance to standards using self-review 
On site observation
On site interviews
Report Description of the organization, positive and 
negative findings, recommendations for im-
provement and comparisons with standards
Compliance and non-compliance with standards of 
the accreditation programme
Certification None Yes, accreditation
Disclosure Confidential Public
Table 1. Key features and differences of external peer review and accreditation (Heaton 2000; Klazinga et al. 2011)
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Despite inconsistent evidence, the programmes are adopted worldwide, requiring significant 
amounts of labour and money. Given these investments and the lack of evidence on the impact 
of these programmes, the call for evidence grew (Shaw, 2001; Greenfield and Braithwaite, 2009).
There are several reasons for the lack of consistent evidence, depending on programme features, 
methodological research challenges and difficulties in relating the outcomes to the programmes 
(van Harten et al, 2000; Ovretveit and Gustafson, 2002; Ovretveit, 2002; Ovretveit and Gustafson, 
2003). In general, it is not totally understood how quality of care can be defined and measured, 
nor which factors are responsible for quality improvement. The most solid method to prove 
the impact of any intervention is a ‘traditional’ randomised clinical trial, but this is not always 
possible. In our study we therefore did not attempt to perform a review on the outcomes of 
previous studies.  We focussed on why the evidence is inconclusive and what can be done to 
improve future research in this field. The purpose of this review is to assess the methodological 
characteristics of international studies on the impact of accreditation and external peer review 
on the quality of care in order to create a general research framework. This framework could 
support researchers in determining the most appropriate research approach to study the effect 
of these programmes and facilitate comparisons between studies.
Methods
A literature search on the impact of external peer review (visitatie) and accreditation programmes 
in healthcare was conducted in November 2012. These two methods of external quality 
assessment share common grounds and are the closest to the actual delivery of healthcare and 
were therefore included in the search. Programmes such as ISO and EFQM were not included 
as these primarily target managerial and process-related conditions. We focused on clinical 
literature and searched the Pubmed/Medline, Embase and Web of Science databases. We looked 
for studies that examined the impact of accreditation or external peer review programmes on 
healthcare quality-related outcomes. In our search strategy, no differentiation was made in 
organisational vs speciality programmes or voluntary vs mandatory programmes. Outcomes 
nor the content of the programmes were specified, which makes it difficult to narrow down 
results of a search strategy. We tested different MeSH and Emtree terms (Pubmed/Medline 
and Embase) and used accreditation, Joint Commission on Accreditation of Healthcare, peer 
review and benchmarking to search the Pubmed database. Embase and Web of Science were 
searched using the terms: accreditation, peer review, visitatie and joint commission. Visitatie is 
a word originating in the Netherlands (and sometimes used in English publication), external 
peer review is used more frequently internationally. Therefore, both visitatie and peer review 
were included in our search strategy. The results were narrowed down by using terms such as 
‘quality of healthcare’, ‘quality assurance’ and ‘outcome and process assessment’. To obtain our 
final selection we selected only the references with keywords in their titles such as impact, 
outcome(s), difference(s) and effect(s). This was done to filter studies on the impact of the 
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programmes. In addition the search was limited to articles written in English or Dutch (see 
Table 2 for the full search strategy).
Table 2. Literature search strategy and number of retrieved references (N)
Literature database Search entry N
Pubmed/Emtree (accreditation[majr] OR Joint Commission on Accreditation of Healthcare Organizations[majr] OR 
Benchmarking[majr] OR Peer Review[majr]) AND (Quality of Health Care[majr] OR Organizational 
Culture[majr] OR Quality Assurance, Health Care[majr] OR Quality Indicators, Health Care[majr] 
OR Total Quality Management[majr] OR Safety Management[majr]) AND ((Efficiency, Organizati-
onal[majr] OR “Outcome and Process Assessment (Health Care)”[majr] OR “Outcome Assessment 
(Health Care)”[majr] OR “Medical Errors/prevention and control”[majr]) OR ((Health Services[-
majr] OR Health facilities[majr]) AND (standards[sh] OR ut[sh] OR sn[sh]))) AND (review[ti] OR 
accredit*[ti] OR impact[ti] OR improv*[ti] OR effect[ti] OR effectiv*[ti] OR audit[ti] OR audit*[ti]) 
NOT laboratory
1501
Embase 1. ‘accreditation’’/mj
2. ‘visitatie’ 
3.  ‘peer review’’/mj 
4.  ‘joint commission’ 
5. 1 or 2 or 3 or 4 -->18637
6. ‘health care quality’/mj 
7. ‘health services research’/mj                            
8. ‘quality control’/mj 
9. ‘outcome assesment’/mj
10. ‘error’/mj
11. ‘health care facilities and services’/mj
12. ‘health services research’/mj
13. ‘safety’/mj 
14. ‘organization and management’/mj
15. #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 -->  269162
16. #5 AND #15 --> 667
17. Outcome*:ti OR compar*:ti OR difference*:ti OR error*:ti OR performance:ti 
                            -->2679383
18. #16 AND #17 
101
Web of Science 1.                         Topic=(accreditation) OR Topic=(visitatie) OR Topic=(“peer review”) 13816
2. Title=(compar*) OR Title=(difference*) OR Title=(error*) Title=(outcome*) OR
                             Title=(effect*) OR Title=(impact) OR Title=(performance) 4310912
3. Topic=(health) OR Topic=(care) 1352312
4. 1 AND 2 1368
5. #4 refined by document type (article or review) and (language English/Dutch)
                            1157
6.  5 AND 3 
499
Total number of references 2101
After deleting double references 2025
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We used an extensive search strategy because we could not filter references based on type of 
accreditation programme or type of outcome variables. Using keywords and title words to 
narrow down our results was needed to reach an acceptable amount of references. The risk 
of losing relevant references by this strategy was acknowledged and an intensive search of the 
reference lists of our retrieved studies was done to find studies that were not identified by the 
initial search effort. We felt comfortable doing this because we also studied the reference lists of 
two previous well-known studies on accreditation (Greenfield and Braithwaite, 2008; Hinchcliff 
et al., 2012). 
The abstracts were independently analysed by three researchers (MK, WVH, SS). Disagree-
ments were solved by consensus. The inclusion criterion was: original research on the impact 
of accreditation or external peer review on quality related outcome measures (incorporating 
structural, procedural and outcome related quality indicators). We did not specify specific 
outcomes because accreditation programmes can focus on different process, structure, and 
outcome variables (including quality of life of patients). Therefore, all structure, process or 
outcome related measures were included in our review. Exclusion criteria were: settings that 
do not deliver direct patient care (e. g. laboratories), evaluations of (singled out) accreditation 
standards instead of the entire programmes, evaluations of substance abuse programmes, pro-
gramme assessments and the absence of quality related measures such as financial impact and 
costs-effectiveness. 
Qualitative evaluation
No existing hierarchy of evidence framework was used to rank the quality of the studies. 
Common hierarchy of evidence frameworks are suited for experimental situations but lack 
differentiating criteria for studies on quality improvement programmes. In order to evaluate the 
studies we assessed several methodological characteristics. The following items were extracted 
from each paper: the objectives, study approach, focus of the studied programme, heterogeneity 
of the study population and theoretical frameworks, analysis entity and the presence of a 
control group. The focus of the studied programme was categorised as either the healthcare 
organisation as a whole (organisation) or a specific medical specialism or disease (service). 
Multiple hospitals including different subspecialties were rated as a highly heterogeneous study 
population and multiple hospitals only focussing on one or two specialties as low. 
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Figure 1: Study selection
Records identied through database searching 
(N=2,101)
Pubmed/Medline 1,501, Embase 101, WoS 499
Records after duplicates removed and abstract 
only removed
(N=2,025)
Records screened on title 
and abstract 
(N=2,025)
Full-text articles assessed 
for eligibility 
(N=52)
Additional references in 
reference lists
(N=10)
Total number of studies 
included
(N=50)
Records excluded
(N=1,973)
Full-text articles 
excluded, with 
reasons (N=12)
-not evaluating 
eects on quality of 
care (10)
- No accreditation 
(2)
Results
Search results
A total of 2,101 references were identified, after deleting the double references 2,025 publications 
remained. After careful screening of the titles and abstracts, 52 articles were selected. The 
full texts were studied and 40 articles qualified. By examining the reference lists another ten 
references were retrieved. In total, 50 articles were included in our review (Figure 1 for a 
flowchart of the literature search). Their characteristics are presented in Table 3.
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Methodological characteristics
Objectives 
The studies can be divided into two categories. First there are studies on ‘the differences between 
hospitals after accreditation’. Their objectives are characterised by the question whether there 
is an association or relationship between accreditation status or scores and performance on 
quality indicators. These objectives implicate a static comparison on a certain moment in time 
and are tested by comparing performance measures to accreditation scores or measures from 
accredited hospitals to non-accredited hospitals. Second, we found studies with the objective 
to evaluate the impact or effect of a programme (on the quality of care). Key difference of an 
impact study is the evaluation of the added value of the programme. Instead of testing whether 
organisations differ the focus is on the achievements of the programme, mostly through a 
longitudinal design.
Study approach
In total, 27 of the 50 studies used a cross-sectional study design. Studies that aggregated data 
that was gathered over several years (e.g. survival data) were categorised under cross-sectional 
research. A cross-sectional, quantitative approach was the most prevalent as 52 per cent of the 
cross-sectional studies used this approach. A great benefit proves to be the large sample sizes 
that can be attained, as the high numbers of included hospitals and patients in cross-sectional 
studies show (Table 3). Most of these studies used large administrative databases such as the 
annual survey data of the American Hospital Association (AHA). A cross-sectional study-
design is generally favoured for its low costs, absence of follow-up time and easy accessibility of 
mostly administrative data. The main shortcoming of cross-sectional studies is that they only 
address the question whether there are differences between hospitals; these can be explained by 
the accreditation status but other external and internal factors cannot be excluded. Therefore, 
results from a cross-sectional study have to be put in perspective and other possible causal or 
interfering factors need to be considered. 
To evaluate the impact of accreditation the added value needs to be studied. This was done 
by analysing changes by using a longitudinal approach, the simplest one being a before-after 
study. In total, 23 studies were performed longitudinally. Longitudinal studies had smaller 
study populations. In nine studies a small population was studied more extensively (Simons 
et al., 2002; Pomey et al., 2004; Stradling et al., 2007; Paccioni et al, 2008; Awa et al., 2010; Kim et 
al., 2010; Sack et al., 2010; al Awa et al., 2011a; al Awa et al., 2011b). These studies were done to 
gain more insights in how accreditation is perceived and what subsystems and cultural variables 
are affected. This strategy does create problems with respect to the external validity. Pomey et 
al. (2004) published one study on the accreditation of a single university hospital and more 
recently one on the accreditation of five healthcare organisations (Pomey et al., 2004; Pomey et 
al., 2010). In the latter study they stated not to aim for the best internal and external validity but 
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to study a small number of cases in detail. Instead of focussing on outcomes, they evaluated how 
the accreditation process helped to introduce organisational changes. Similarily, Paccioni et al. 
used a study population of two primary care centres to gain understanding of the dynamics and 
impact of accreditation from a cultural control point of view (Paccioni et al, 2008).
Another approach we encountered to study added value was the examination of a dose-response 
relationship between hospitals in different phases of accreditation. Gratwohl et al. (2011) 
managed to include 421 bone-marrow transplantation centres. Centres were divided in those 
who were not accredited, preparing for accreditation, applied for accreditation, in the process 
of accreditation and accredited. A dose-response relationship was found with systematically 
better outcomes in the centres that were at a more advanced phase of accreditation. 
Programme focus
Organisation-focussed programmes consist of multiple components and impact can be 
expected in multiple outcome categories. Research on programmes with an organisational 
focus tends to use groups of outcome variables rather than single outcome variables. Looking 
at the objectives, this is shown by the aim to evaluate the impact on broad outcome categories 
such as ‘organisation’, ‘quality management’ or ‘safety measures’. These categories include 
several variables such as: availability of guidelines and protocols, number of readmissions and 
number of complications. Braithwaite and Greenfield (2010) state that all the components of 
a (complex) hospital system are interdependent and that there is interaction between all the 
different components. They plead that complex programmes like accreditation need a multi-
method evaluation combining quantitative and qualitative data to explore all the different 
components. We found eight other studies that used a mixed method evaluation (Salmon et al, 
2003; Juul et al., 2005; Paccioni et al, 2008; Sunol et al., 2009; Roberts et al., 2010; Shaw et al., 2010; 
El-Jardali et al., 2011; Roberts et al., 2012).
Studies on service-focussed programme primarily use clinical process and outcome variables 
such as therapeutic guideline adherence, morbidity and mortality (Pasquale et al., 2001; Simons 
et al., 2002; Chen et al., 2003; Juul et al., 2005; Stradling et al., 2007; Ross et al., 2008; Chandra et 
al., 2009; Gratwohl et al., 2011; Lichtman et al., 2011). It seems that it is easier to select specific 
care-related outcome variables when the programme is directly targeting one specific service 
or disease.
Study population and theoretical frameworks
A logical theoretical framework can be used to create structure and hypothesise on how 
outcomes can be related to the programme. It is suggested that the need of a theoretical 
framework increases when the studied programme is more heterogeneous (e.g. organisational 
focus) and when there is a wider variation in the organisations studied (Walshe et al., 2001). 
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Studies on service-focussed programmes applied to homogeneous organisations are closer 
to an experimental situation which justifies the use of more experimental methods (and 
care-related outcomes). We considered a theoretical framework to be present if there was an 
explicit description in manuscript of how the authors expected the programme to affect the 
outcome variables. In total, 34 papers concern studies that focus on the accreditation of whole 
organisations, seven of them use a theoretical framework. Other studies gave arguments for 
the impact of accreditation programmes such as the standardisation of processes and better 
guideline adherence but did not explicitly rely on a theoretical framework. 
Thornlow and Merwin (2009) refer to the Quality Health Outcomes Model to structure the 
relationships between system, intervention and outcomes (based on Donabedian’s structure, 
process and outcomes model). System variables were hospital characteristics, intervention 
variables were defined as utilisation of patient safety practices and outcomes were defined by 
the Agency for Healthcare Research and Quality. A fourth construct ‘client’ was added and 
defined as risk-adjusted variables including diagnosis, age and gender. A study on the impact 
of accreditation in U.S. nursing homes used Donabedian’s original model (Wagner et al, 2012a). 
Braithwaite et al. (2010) research programme identified five major variables: organisational 
performance, clinical performance indicators, organisation culture, consumer participation 
and accreditation performance. A simplified model was made of the inter-relationships between 
these variables. Causal relationships could not be established due to potentially confounding 
variables. Instead qualitative and quantitative methods were combined to examine associations 
between the five major variables. Pomey et al. (2004;2010) used a self-designed model in both 
studies that evolves around the dimensions of change. This consists of conditions favouring 
emergence and diffusion of change and the characteristics of change. Accreditation is regarded to 
be an agent of change. Paccioni et al. (2008) describe a culture-approach, in which accreditation 
is a method to influence culture in a hospital. 
Analysis entity
Outcomes can be analysed on a macro-level (healthcare systems), meso-level (healthcare 
organisations) and micro-level (patients). There is no consistent usage of these levels. Gratwohl 
et al. (2011) studied the effects of JACIE accreditation on patient survival after stem cell 
transplantation. Patients were grouped according to the accreditation status of the centre where 
they were treated. This micro-level evaluation allowed them to measure the accreditation effect 
instead of a centre effect and created the possibility to put the programme impact in perspective 
to other (possible) influencing variables. Most other studies used entire organisations as 
analysis entity, aggregating clinical data per hospital and categorising the hospitals according to 
their accreditation status. Aggregation of data may lead to problems. When data is aggregated 
from micro-level to meso-level, information might be lost and the analysis can lose power 
(aggregation bias). Another problem is the interpretation of results; conclusions are being 
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made on aggregated data from heterogeneous populations as if they came from a homogeneous 
population. Outcome categories were primarily clinical (e.g. survival), organisational or safety 
(e.g. medication errors). Some studies investigated the impact on patient perception (e.g. 
patient satisfaction) or provider perception.
Control group
Most studies (N=35) used a control group of non-accredited hospitals. Adding a control group 
creates a quasi-experimental situation, as it is often not possible to randomly assign hospitals 
to the control group. Not all the studies had the possibility to include a control group. In order 
to create different groups, some studies used the accreditation scores to investigate a dose-
response relationship.
Implications for future research
This review provided insight in important methodological challenges in studying the impact 
on quality of care. It also revealed how some studies were able to overcome these challenges 
by the choice of their study design and use of a theoretical framework such as the structure, 
process, outcome model. We summarised our findings in a framework (Figure 2). Following the 
methodological aspects we studied, it graphically shows what steps should be taken to evaluate 
an external quality assessment programme. In eight simple steps this framework can help to 
choose a research approach for future studies:
1.  There are two categories of research objectives: research on differences between organisations 
based on their accreditation status/scores and research on the impact of a programme, which 
evaluates the added value.
2.  Study approach depends on the objective of the study. A cross-sectional study can serve 
to analyse the association between accreditation status or scores and performance measures. 
A longitudinal approach has more explanatory power and is more suited to study the impact 
of accreditation by assessing changes in organisations. Studying a quasi-experimental dose-
response relationship can also provide information on the added value of accreditation
3.  Describe the programme and study population as the choice for outcome measures depends 
on the organisational or service focus of the studied programme. 
4 and 5. In an evaluation of an organisation focussed programme the different components of 
the healthcare system can be explored by a mixed-method evaluation. Use of more care-related 
outcome variables seems to be justified in studies on service focussed programmes. 
6.  The need for a theoretical framework increases when studying an organisation focussed 
programme or when there is a heterogeneous study population. Complicated relationships exist 
between variables such as structure, processes, culture and clinical performance. A theoretical 
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framework can be used to describe the direct influence of the programme on these variables 
and the expected indirect effects.
7.   A control group creates a quasi-experimental situation as randomization to the programme 
is often not possible. In the absence of a control group a dose-response relationship based on 
accreditation scores can be investigated.
8.  The choice of outcome entity decides on which level conclusions can be drawn. When 
studying the effects on a micro-level, non-aggregated data is favoured.
 
To study the impact of the 
programme 
To study differences between 
accredited vs. non-accredited 
hospitals 
Assess changes 
(longitudinal design) or 
evaluate a dose-response 
relationship 
Cross-sectional design 
Homogenous study population 
and service focussed 
programme 
Heterogeneous study 
population and/or 
organisation focussed 
programme 
Mixed methods
Define outcome variables. A 
theoretical framework is less 
relevant. 
 
Experimental methods
Construct theoretical 
framework and define 
outcome variables 
 
  1. Objective 
What is the study objective? 
2. Study approach 
Choose the study approach 
depending on your objective 
3. Study population & programme 
Describe the programme and population that you are studying 
4. Organisation or service 
focus and heterogeneity of 
the organisations
5. Methods
Choose the methods based 
on the focus of the 
programme and organisation 
6. Theoretical framework 
and outcomes 
Choose which outcome 
variables to study. An 
explaining theory may be 
needed 
7. Control group and confounding factors 
Adding a control group creates a quasi-experimental situation. 
Try to correct for as many confounders as possible 
8. Results on appropriate outcome level (macro-, meso-, microlevel) 
Choose on which level you want to study your outcomes, varying from entire healthcare systems to an 
individual patient level 
Figure 2. General research framework for external quality assessment programmes. 
The methodological aspects correspond with the review items
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Discussion and conclusion 
The evidence for the impact of accreditation and external peer review on the quality of care 
is still inconclusive. Although multiple studies have been performed internationally, previous 
reviews struggled to draw hard conclusions (Greenfield and Braithwaite, 2008; Hinchcliff et al., 
2012). Because of the difficulties in studying complex interventions we reviewed international 
research by their methodological characteristics to develop a general research framework. More 
uniformity in research methods and avoiding the pitfalls of research on complex interventions 
can create a stronger evidence base for accreditation and external peer review. 
We deliberately kept the framework simple. By using the framework, researchers can decide if 
their study design will benefit from a theoretical framework to explain their results. Also, the 
need for mixed methods or a more experimental design can be assessed. As the call for evidence 
grows (particularly on clinical outcomes), we advice that future studies include specific clinical 
process and outcome indicators such as guideline adherence or patient safety. This might also 
improve acceptance for the programmes amongst professionals. Future studies should avoid 
a cross-sectional design. Longitudinal studies, or at least the evaluation of a dose-response 
relationship is needed to study the added value of the programmes.
A critical research obstacle that remains is that many of the studied programmes do not 
primarily intent to improve outcomes but rather focus on organisation and processes. We 
believe that in the current era of evidence-based medicine, quality improvement programmes 
need to step up to become effective tools with an impact on care processes and outcomes. This is 
also the reason why we focussed on accreditation and external peer review and did not include 
programmes like ISO-certification. Omitting these programmes will not have a major impact 
on our developed framework, since this framework is intended for studies on clinical outcomes. 
We specifically restricted our study selection to publications on the impact of the programmes on 
quality-related outcomes. Because of our selection criteria we ended up with fewer articles than 
previous reviews on the impact of accreditation (Greenfield and Braithwaite, 2008; Hinchcliff 
et al., 2012). This strategy holds the risk of missing key literature. We used the reference lists 
of the articles to find studies that were not captured by the initial literature search. We believe 
that we have retrieved a sufficient amount of relevant papers to study a variety of different 
methodologies in order to create our general research framework. There was a large variation 
in programmes and outcomes varying from organisation-related outcomes to patient-related 
outcomes. The study by Kim et al. (2010) reports on a more ‘technical outcome’. This study was 
included in our definite selection because it concerns an accreditation programme that targets 
quality improvement in an important process related outcome variable: CT image quality. 
Image quality is directly related to the quality of the diagnosis, subsequent staging and thus 
treatment (Kim et al., 2010). As we experienced, a literature review on a complex intervention 
like accreditation is difficult because of the large variety of programmes and outcomes. Future 
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studies on how evidence from studies on complex interventions can be used to create a body of 
evidence might appeal to researchers and programme makers worldwide.
 
Overall, our framework could be used to structure further research in this field and improve 
our knowledge on the impact of accreditation and external peer review. Future studies can 
also benefit if programme makers establish clear and measurable goals for their programmes. 
Outcome variables to evaluate the programmes need to be defined in advance to increase the 
possibilities for evaluation. More and better research can be used to improve quality assessment 
all over the world and generate more understanding and acceptance for the burden that 
accreditation and external peer review inevitably brings along.
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The impact of organisational external peer review on colorectal 
cancer treatment and survival in the Netherlands
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Abstract
Background
Organisational external peer review was introduced in 1994 in the Netherlands to improve 
multidisciplinary cancer care. We examined the clinical impact of this programme on colorectal 
cancer care. 
Methods
Patients with primary colorectal cancer were included from 23 participating hospitals and 7 
controls. Hospitals from the intervention group were dichotomised by their implementation 
proportion (IP) of the recommendations from each peer review (high IP vs. low IP). 
Outcome measures were the introduction of new multidisciplinary therapies and survival.
Results
In total, 45705 patients were included (1990-2010). Patients from intervention hospitals 
more frequently received adjuvant chemotherapy for stage III colon cancer. T2-3/M0 rectal 
cancer patients from hospitals with a high IP had a higher chance of receiving preoperative 
radiotherapy (OR 1.31, 95% CI 1.11-1.55) compared with the controls and low IP group (OR 
0.75, 95% CI 0.63-0.88). There were no differences in the use of preoperative chemoradiation 
for T4/M0 rectal cancer. Survival was slightly higher in colon cancer patients from intervention 
hospitals but unrelated to the phase of the programme in which the hospital was at time of 
diagnosis.
Conclusion
Some positive effects of external peer review on cancer care were found, but the results need to be 
interpreted cautiously due to the ambiguity of the outcomes and possible confounding factors. 
47The impact of external peer review on colorectal cancer care
Introduction
Delivering high quality care is key to any modern healthcare system. External quality 
assessment programmes are more and more considered as a cornerstone in the assessment and 
improvement of quality. Internationally, accreditation is the most commonly used method. In 
the Netherlands, external peer review (visitatie in Dutch, meaning “to visit”) is the dominant 
external quality assessment method and this approach is slowly gaining popularity in Europe 
[Heaton, 2000, van Weert, 2000]. Organisational external peer review for cancer care was 
introduced in the Netherlands in 1994. In England, National Cancer Peer Review (NCPR) was 
introduced as part of the National Cancer Programme in 2004, after a first round of peer review 
was conducted at a regional level in 2001 [National Cancer Peer Review Programme, 2012]. The 
English programme focusses on performance for specific tumour groups, whereas the Dutch 
programme targets the multidisciplinary cancer care organisation in hospitals as a whole.
When the external peer review programme was introduced in the Netherlands in 1994, treatment 
of cancer patients was predominantly monodisciplinary. Since then, multidisciplinary cancer 
care has become the standard. The programme was introduced by the Comprehensive Cancer 
Centre North Netherlands. The nine Comprehensive Cancer Centres, covering the whole 
Netherlands, are regional network organisations of health care professionals and institutes 
for cancer and palliative care aiming at improving cancer care through research, guideline 
development, knowledge exchange and organisational improvement without having a treatment 
function themselves. The peer review programme was first introduced in the Northern 
Netherlands and gradually spread over the country. Surveyors are all specially trained medical 
and nursing specialists, which results in a natural understanding of the daily challenges faced in 
the treatment of cancer patients; in this way the system is supposed to generate recognition and 
involvement of professionals. Participation is voluntary and hospitals are advised to participate 
every 4-5 years. A majority of Dutch hospitals has gone through the procedure at least once 
and in some regions already thrice. Using self-assessment, on-site observation and interviews, 
the state of cancer care in a hospital is evaluated and recommendations for improvement are 
given. Major topics of recommendations were the organisation of weekly multidisciplinary 
patient care meetings, shared decision making between specialists, oncological specialisation 
of medical specialists, dedication of oncology committees to policy making, introduction of 
integrated care pathways, referral policies for low volume tumours and highly complicated 
interventions and working according to evidence-based guidelines. 
Few studies have been published on the clinical impact of external peer review. Roberts et 
al. report on the 1- and 3-year evaluation of peer review for chronic obstructive pulmonary 
disease in the UK [Roberts et al, 2010, Roberts et al, 2012]. Findings after 3 years indicated an 
association with improved quality of care, service delivery and changes that promote quality 
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improvement [Roberts et al, 2012]. The 1-year evaluation revealed no differences showing that 
changes need a longer period to occur [Roberts et al, 2010]. More studies have been done on the 
effects of accreditation but the evidence remains uncertain [Greenfield and Braithwaite, 2008, 
Hinchcliff et al, 2012]. Due to high financial and labour investments, calls have been made for 
more research concerning the clinical impact of these programmes [Greenfield and Braithwaite, 
2009, Shaw, 2001].
The purpose of our study is to investigate whether (1) the participation in the external peer 
review programme focussing on multidisciplinary cancer care and (2) the extent of the 
implementation of the peer review recommendations impacted multidisciplinary treatment 
patterns (such as combined treatment modalities) and survival of colorectal cancer patients. 
Colorectal cancer was amongst the first types of cancer requiring multidisciplinary treatment. 
Due to new treatments, the quality of care has improved significantly in the last 20-30 years. 
[Elferink et al, 2010a, van Steenbergen et al, 2010a]. Studies have proven that regional and 
inter-hospital treatment variation exists that cannot be explained by medical factors only. It is 
suggested that hospital characteristics have a role in this variation [Elferink et al, 2010b, Elferink 
et al, 2010c]. Three major therapy changes requiring multidisciplinary cooperation have been 
introduced in the period under study: (1) the introduction of adjuvant chemotherapy in stage 
III colon cancer, (2) the introduction of preoperative radiotherapy in T2-T3 rectal cancer and 
(3) the introduction of preoperative chemoradiation in T4/M0 rectal cancer and tumours 
with an expected positive circumferential margin (CRM).[Dutch national working group 
on gastrointestinal cancer, 2012] We hypothesised that the willingness of a hospital to have 
external peer review and to follow the recommendations from it is correlated to the hospital 
giving higher quality of colorectal cancer treatment measured by the introduction of new 
multidisciplinary therapies and better survival of the colorectal cancer patients. 
Material and Methods
Design and patients
We selected all patients diagnosed with primary invasive epithelial colorectal cancer (ICD-O3, 
codes: colon C18.0-18.9, rectum C20.9) between 1 January 1990 and 31 December 2010 from 
the population-based Netherlands Cancer Registry. Patients diagnosed at autopsy, during an 
emergency operation or with previous malignancies were excluded. Patients from hospitals 
from the two regions where the programme was introduced first (Northern Netherlands and 
Rotterdam/South-west regions) form the intervention group. All hospitals in these regions 
voluntarily participated in the programme. The control group consists of patients from seven 
hospitals with otherwise comparable characteristics that did not participate before 2009, 
because the programme as such was not yet available in all regions. 
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Within the Netherlands Cancer Registry clinical administrative data of every newly diagnosed 
cancer patient in the Netherlands are collected. Topography and morphology are coded 
according to the International Classification of Diseases for Oncology and staging according to 
the TNM classification. Follow-up of vital status is achieved by linking the registry to municipal 
records. Quality of the data is high [Schouten et al, 1993a] and data completeness is estimated to 
be at least 95% [Schouten et al, 1993b]. 
The treatment and survival analyses are based on the hospital were the patient was diagnosed. 
Some patients may have been referred for treatment but this is considered as a good standard 
of care of the referring hospital. Furthermore, referral policies for low-volume tumours were 
an important topic of the external peer review programme. We used the implementation 
proportion (IP) of all the recommendations given in the final reports of each peer review as a 
measure for the willingness of a hospital to implement the recommendations and the quality of 
colorectal cancer care. Data on the IP were obtained by studying the peer review reports, follow-
up correspondence, hospital documents and interviews with stakeholders. Implementation was 
ranked per recommendation on a scale from 0 to 4 in which 4 represents total implementation 
and 0 a not implemented recommendation (Appendix 1). Scores per hospital were expressed as a 
percentage of the total score that could be achieved. When implementation of a recommendation 
could not be assessed (no data), the recommendation was subtracted from the total possible 
score. We used the average IP of all peer reviews per hospital because the time period in which 
changes can occur is unknown and quality improvement is a continuous process. Data from 
three cycles of peer review (1994-2009) were used from the Northern Netherlands and data 
from two cycles (1996-2006) from the Rotterdam region. A third cycle was completed in the 
Rotterdam region between 2009 and 2011 but follow-up time was too short to monitor the IP. 
We did not make assumptions on what a high or a low IP is and therefore dichotomised the 
hospitals in the intervention group into two categories: (1) hospitals with the highest IP and (2) 
with the lowest IP. 
Hospitals were asked for permission to use their data from the Netherlands Cancer Registry 
and programme reports. We excluded university hospitals and hospitals that merged during 
our study period since it was impossible to determine the IP. 
Multidisciplinary treatment patterns
We studied the impact of the programme on the introduction of three major changes 
in multidisciplinary treatment: (1) adjuvant chemotherapy in stage III colon cancer, (2) 
preoperative radiotherapy in T2-T3/M0 rectal cancer and (3) preoperative chemoradiation in 
T4/M0 rectal cancer. Preoperative chemoradiation is also recommended in rectal cancer patients 
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with tumours with an expected positive circumferential margin (other than T4 tumours) but 
the Netherlands Cancer Registry does not provide data on the expected margin. We therefore 
focussed on the T4/M0 patients for the implementation of the preoperative chemoradiation. 
All patients with T2-3/M0 tumours, irrespective of their circumferential margin, are therefore 
included in the analyses for preoperative radiotherapy as this is the minimal treatment they 
should have received. 
Survival
The association between the programme and survival was evaluated for the complete cohort 
subdivided in colon and rectal cancer patients. To examine the impact of the different 
programme phases on survival, we compared the 5-year survival of patients with the phase in 
which the hospital was at time of diagnosis. 
Statistical Analyses
Clinical stage was used in our analyses for preoperative radiotherapy for T2-3/M0 rectal cancer 
patients and preoperative chemoradiation for T4/M0 rectal cancer patients. In case clinical 
stage was unknown it was substituted by pathological stage. Pathological stage was used for 
analysing the use of adjuvant chemotherapy in stage III colon cancer and survival, clinical stage 
was used when pathological stage was unknown. We excluded patients aged ≥75 years for the 
analyses of the introduction of chemotherapy in stage III colon cancer and chemoradiation in 
T4/M0 rectal cancer to prevent a bias as elderly patients are known to receive systemic therapy 
less frequently [Elferink et al, 2010b, Elferink et al, 2010c].
Multivariate logistic analysis was used to analyse the variation in treatment and the influence 
of participating in the programme and the IP, corrected for gender, age at diagnosis, year of 
diagnosis, average hospital volume of diagnoses and presence of an in-hospital radiotherapy 
department. Because all analyses concern adjuvant therapy, only operated patients are included 
in the treatment analyses. 
Using Cox’s proportional hazards model we examined differences in hazard of dying adjusted 
for gender, age at diagnosis, year of diagnosis and average annual hospital volume of diagnoses. 
Survival time was defined as the period from incidence to date of death (all causes) or censuring 
(31-12-2011 or emigration date). For all analyses STATA version 12.0 (StataCorp, College 
Station, TX, USA) was used. 
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Results
Population
We requested permission of 26 hospitals from the Northern Netherlands and Rotterdam region 
to use the data from their peer reviews and the Netherlands Cancer Registry, 23 hospitals gave 
their permission. Seven out of twelve hospitals without experience with the programme agreed 
to be included in the control group. In total, 45 705 patients were diagnosed with colorectal 
cancer in these 30 hospitals (about 1 out of 3 of all hospitals in the Netherlands) between 1990 
and 2010, 31890 patients with colon cancer and 13815 patients with rectal cancer. A schematic 
overview of the study population at each phase of our study is presented in Appendix 2. 
Implementation of programme recommendations
In the three cycles of peer review in the Northern Netherlands and two cycles in the 
Rotterdam region 727 recommendations were given to the hospitals. This is an average of 12 
recommendations per peer review per hospital. The intervention group was dichotomised in 12 
hospitals with a high IP (average 62.6%) and 11 hospitals with a low IP (average 44.8%). Table 
1 shows the patient characteristics of the population of colon and rectal cancer patients for the 
intervention and control groups.
Variable Intervention group  High IP
(12 hospitals)
Intervention group Low IP
(11 hospitals)
Controls
(7 hospitals)
Colon cancer
Sex
Male 
Female 
5555 (48.4)
5924 (51.6)
5211 (48.8)
5463 (51.2)
4835 (49.7)
4902 (50.3)
Mean age at diagnosis
<60
60-74
>74
2071 (18.0)
4694 (40.9)
4714 (41.1)
1939 (18.2)
4520 (42.4)
4215 (39.5)
1907 (19.6)
4309 (44.3)
3521 (36.2)
Period of diagnosis
1990-1995
1996-2001
2002-2007
2008-2010
2710 (23.6)
3080 (26.8)
3535 (30.8)
2154 (18.8)
2381 (22.3)
2867 (26.9)
3472 (32.5)
1954 (18.3)
2100 (21.6)
2559 (26.3)
3051 (31.3)
2027 (20.8)
Stage
1
2
3
4
Carcinoid
Unknown
1761 (13.5)
4026 (35.1)
2945 (25.7)
2392 (20.8)
36 (0.3)
319 (2.8)
1683 (15.8)
3823 (35.8)
2694 (25.2)
2174 (20.4)
30 (0.3)
270 (2.5)
1317 (13.5)
3626 (37.2)
2421 (24.9)
2055 (21.1)
29 (0.3)
289 (3.0)
Average annual volume of 
hospital of diagnoses
<50
50 or more
6070 (52.9)
5409 (47.1)
6856 (64.2)
3818 (35.8)
2437 (25.0)
7300 (75.0)
Table 1 (part 1). Characteristics of the cohort of colon (N= 31890) cancer patients per hospital category, 1990-
2010, data are no(%). IP= Implementation Proportion
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Rectal Cancer
Sex
Male 
Female 
2804 (57.2)
2100 (42.8)
2696 (58.8)
1888 (41.2)
2597 (60.0)
1730 (40.0)
Mean age at diagnosis
<60
60-74
>74
1192 (24.3)
2099 (42.8)
1613 (32.9)
1087 (23.7)
2050 (44.7)
1447 (31.6)
1153 (26.7)
1975 (45.6)
1199 (27.7)
Period of diagnosis
1990-1995
1996-2001
2002-2007
2008-2010
1045 (21.3)
1274 (26.0)
1628 (33.2)
957 (19.5)
977 (21.3)
1183 (25.8)
1511 (33.0)
913 (19.9)
896 (20.7)
1077 (24.9)
1372 (31.7)
982 (22.7)
Stage
1
2
3
4
Carcinoid
Unknown
1352 (27.6)
1139 (23.3)
1262 (25.7)
808 (16.5)
13 (0.3)
330 (6.7)
1324 (28.9)
1089 (23.8)
1127 (24.6)
762 (16.6)
18 (0.4)
264 (5.8)
1135 (26.2)
1058 (24.5
998 (23.0)
756 (17.5)
18 (0.4)
362 (8.4)
Average annual volume of 
hospital of diagnoses
<25
>25
3039 (62.0)
1865 (38.0)
3829 (83.5)
755 (16.5)
1572 (36.3)
2755 (63.7)
Multidisciplinary treatment patterns
Out of the colon cancer patients, 4969 surgically treated patients under 75 years of age patients 
had stage III. Patients with stage III colon cancer who were diagnosed in hospitals in the inter-
vention group received adjuvant chemotherapy more frequently compared to the control group 
(Table 2). This was seen in both the high IP and the low IP intervention hospitals (OR 1.48, 95% 
CI 1.25-1.75 and OR 1.19, 95% CI 1.00-1.41). 
Hospital category OR 95% CI
Adjuvant chemotherapy stage III 
colon carcinoma 
Control group
Intervention group
- high IP
- low IP
1.00
 1.33*
 1.48*
 1.19*
Reference
1.15-1.55
1.25-1.74
1.00-1.41
Preoperative radiotherapy T2-T3/
M0 rectal cancer 
Control group
Intervention group
- high IP
- low IP
1.00
0.98
 1.31*
  0.75*
Reference
0.96-1.14
1.11-1.55
0.63-0.88
Preoperative chemoradiation T4/
M0 rectal cancer
Control group
Intervention group
- high IP
- low IP
1.00
1.27
1.11
1.48
Reference
0.81-2.01
0.89-2.46
0.67-1.83
Table 1 (part 2). Characteristics of the cohort rectal cancer patients (N= 13815) per hospital category, 1990-2010, 
data are no(%). IP= Implementation Proportion
Table 2. Odd’s ratio’s (OR) for receiving new multidisciplinary treatment per hospital 
category, adjusted for age, gender, year of diagnosis, average annual hospital of diagnoses. 
CI= Confidence Interval, IP= Implementation Proportions. Adjustment for the presence of 
in-hospital radiotherapy department has been made for preoperative radiotherapy and 
chemoradiation. *P<0.05.
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Figure 1. Introduction of adjuvant chemotherapy for stage III colon cancer (standard since 1990) 
per hospital category based on the implementation proportion (IP) of recommendations given in 
the programme. * Represents statistical significance per year (P<0.05).
An early adopter effect is seen in Figure 1 between 1990 and 2000, but the effect is also seen in 
the later years. 
Concerning the rectal cancer patients, 7804 patients were included in our treatment analyses 
with stage T2-T3/M0 cancer and 689 with T4/M0 rectal cancer. The analyses of the use of 
preoperative radiotherapy for T2-T3/M0 rectal cancer initially showed no difference between 
the control group and the intervention group (table 2). Here the IP mattered as can be seen in 
Figure 2; patients who were diagnosed in the intervention hospitals with a high IP received 
preoperative radiotherapy more often (OR 1.31, 95% CI 1.11-1.55) while patients of interven-
tion hospitals with a low IP had a lower chance (OR 0.75, 95% CI 0.63-0.88) compared with the 
control group. 
No differences were seen in the use of preoperative chemoradiation for T4/M0 rectal cancer 
patients (Table 2). Figure 3 shows that after the year 2000 the proportion of patients receiving 
preoperative chemoradiation rose but no statistically significant differences were seen between 
the intervention and control groups (Table 2). 
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Figure 2. Introduction of preoperative radiotherapy in T2-T3/M0 rectal cancer per hospital 
category based on the implementation proportion (IP) of recommendations given in the 
programme. Official guideline introduction was in 2003. * Represents statistical significance 
per year (P<0.05).
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Figure 3. Introduction of preoperative chemoradiation in T4/M0 rectal cancer (recommend-
ed since 2005) per hospital category based on the implementation proportion (IP) of recom-
mendations given in the programme. * Represents statistical significance per 5-year period 
(P<0.05).
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Figure 4. Average 5-year survival of colon cancer patients per hospital category and phase of the programme at the 
time of diagnosis. IP= Implementation Proportion.
Survival
The hazard of dying for patients with colon cancer was slightly lower in the intervention group 
compared to the control group (HR 0.97, 95% CI 0.94-0.99; Table 3). No statistical significant 
differences were found in the hazard of dying of rectal cancer between the intervention and the 
control group (Table 3). Furthermore, there was no correlation seen between the average 5-year 
survival and the programme phases for both colon and rectal cancer (Figures 4 and 5). 
Hospital category HR 95% CI
Colon cancer Control group
Intervention group
- high IP
- low IP
1.00
  0.97*
0.97
  0.96*
Reference
0.94-1.00
0.93-1.00
0.93-1.00
Rectal cancer Control group
Intervention group
- high IP
- low IP
1.00
0.96
0.98
0.96
Reference
0.92-1.01
0.93-1.03
0.91-1.01
Table 3. Hazard ratio’s (HR) for colon and rectal cancer patients per hospital category, 
adjusted for age, gender, year of diagnosis, average annual hospital of diagnoses. CI= 
Confidence Interval, IP= Implementation Proportions. *P<0.05
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Figure 5. Average 5-year survival of rectal cancer patients per hospital category and phase of the programme at the 
time of diagnosis. IP= Implementation Proportion.
Discussion
To our knowledge, we present a unique long-term evaluation of the relationship between 
external peer review and treatment and survival of cancer patients based on the population-
based data. There are some indications that the peer review increased process related quality 
of care. Participation in the peer-review programme and the proportion of implementation 
of recommendations were associated with a higher proportion of stage III colon cancer 
patients that received adjuvant chemotherapy, whereas for rectal cancer the implementation 
of recommendations seems more relevant as patients diagnosed in hospitals with a high IP 
received preoperative radiotherapy more often. On the other hand, we did not find a difference 
in the percentage of patients receiving preoperative chemoradiation for T4/M0 rectal cancer 
related to participation or IP. Furthermore, a survival difference could only be shown for 
colon cancer, but not for rectal cancer and this did not seem to correlate with the phase of the 
programme.
A complicated association exists between external peer review, multidisciplinary care patterns 
and survival outcomes as many internal and external factors may be influential. Some differences 
in stage III colon cancer treatment for instance were already apparent before the introduction of 
the programme in 1994 (Figure 1). Does the programme as such have added value or do quality 
oriented hospitals also act as early adopters and simply implement recommendations better? 
Absence of a baseline measurement of organisational quality and innovative behaviour makes 
it impossible to answer this question. Based on our findings either relation is possible, but we 
tend to conclude that quality focussed hospitals are more likely to work on continuous quality 
improvement and to behave as early adopters. 
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Inter-hospital and regional variation in the treatment of colorectal cancer patients was shown 
in previous national studies [Elferink et al, 2010b, Elferink et al, 2010c]. Before 2000 there was 
both regional variation in guidelines and in their implementation in the Netherlands. This 
might partly explain differences in the results for adjuvant chemotherapy for stage III colon 
cancer as these are most prominent before the year 2000. The results in our study may also 
have been influenced by clinical trials conducted before official guideline recommendation. 
However, despite possible guideline and trial influences, recent studies still stress the patient- 
and hospital-dependant variation in adjuvant therapy, even after official guideline introduction 
of new therapies in the Netherlands and it is unlikely that this is different in other countries 
[Berrino et al, 2007, Elferink et al, 2010b, Elferink et al, 2010c, Lemmens et al, 2005, van 
Steenbergen et al, 2010b]. Although it is unlikely that guideline and trial influences alone can 
explain the treatment variation, it is very difficult to correct for these factors in studying the 
impact of peer review. 
The average 5-year survival of colon and rectal cancer patients did not appear to be related to 
the phase of the peer review programme in which the hospital was at the time of diagnosis. 
Hazard ratio comparisons showed a significant difference in the risk of dying from colon cancer, 
favouring patients diagnosed in the intervention group. In rectal cancer, hazard ratio’s were 
comparable but not statistically different between the intervention and control group. These 
differences are small and promising but need to be considered with caution. We analysed the 
risk of dying in the complete cohorts of colon or rectal cancer patients in stead of the subgroups 
in which we studied the introduction of new multidisciplinary therapies. Reason for this is that 
especially in rectal cancer these new therapies predominantly have an effect on local control. 
Adjuvant chemotherapy is associated with improved survival in stage III colon cancer [Moertel 
et al, 1990]. For rectal cancer the benefit of preoperative radiotherapy and chemoradiation is 
mainly local control, the impact on survival is smaller and the evidence is more ambiguous 
[Bosset et al, 2006, Colorectal Cancer Collaborative Group, 2001, Folkesson et al, 2005, Kapiteijn 
et al, 2001].
The main weakness of our study (and most studies in this field) is that the impact of other, 
and possibly many, confounding factors could not be assessed. Survival and mortality are 
generally used as the ultimate indicators of quality of care in cancer studies, but are influenced 
by a complex set of internal and external factors and it is difficult to single out the programme 
impact. Hospitals in the control group are likely to have introduced changes in their organisation 
as well, but we are not aware of similar programmes that have been executed. Five hospitals 
from the approached control group and three from the approached intervention group did not 
give permission to use data from the Netherlands Cancer Registry which might influenced our 
results, though the participating set seemed sufficiently representative for the Dutch situation. 
Our research had several characteristics adding to a better understanding of the added value 
of the programme. It was possible to include patients from hospitals without experience in 
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participating in the programme, creating a quasi-experimental situation. Because all hospitals 
in the intervention region participated in the programme (even though three did not give 
permission to use their data in this study), there was no programme participation bias. The 
Netherlands Cancer Registry provided us with reliable data over a long time period making it 
possible to analyse our results on a ‘patient-level’. We did not single out recommendations and 
neither did we address a ‘rank’ of importance to them to assess the programme impact instead 
of the impact of single recommendations. 
Conclusion
Organisation focused external quality assessment programmes have difficulties in demonstrating 
their added value on clinical care. All hospitals are willing to participate in external peer review 
but the proportion of implementation of recommendations of the programme differs. Our data 
shows that some positive effects on cancer care can be expected but the results need to be 
interpreted cautiously. Future research on different types of cancer should assess whether our 
results can be generalised. A qualitative study can examine the perceived impact and influence 
on the sense of ownership amongst cancer specialists.
Improved organisation may be a value per se, especially in complex multidisciplinary treatment. 
However, if external quality assessment should provide measurable benefits for individual 
cancer patients, programmes probably need to focus more on specific aspects of the delivery 
of care and clinical outcomes. This will increase the possibilities to quantitatively evaluate the 
impact on the quality of care. Links with clinical audit systems and national cancer registries 
may lead to the reduction in administrative workload of these programmes and improved 
acceptance for continued external peer review for cancer care in the future.
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Appendix 1: Ranking implementation of recommendations
Implementation score of recommendation Criterium
0 Not implemented at all
1 Hospital only started working on implementing
2 A recommendation consists of two parts and one is imple-
mented
3 Recommendation is implemented but not yet in the entire 
organisation
4 Complete implementation
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Appendix 2: Schematic overview of the study population at each 
phase of the study
Patients with primary invasive colorectal cancer N = 45705
Patients with colon cancer  
N =31890
Patients with rectal
cancer. N =13815
Stadium III colon cancer 
Intervention high IP N=2945
Intervention low IP N=2694
Control N= 2421
Stadium III colon cancer <75yr
Intervention high IP N=1777
Intervention low IP N=1668
Control N=1586
T2/T3 rectal cancer 
Intervention high IP N=2869
Intervention low IP N=2649
Control N=2625
T4/M0 rectal cancer 
Intervention high IP N=471
Intervention low IP N=433
Control N=328
T4/M0 rectal cancer <75yr
Intervention high IP N=308
Intervention low IP N=295
Control N=243
Groups for 
survival analyses
Subgroups for 
treatment 
analyses
Received surgery
Stadium III colon cancer <75yr
Intervention high IP N=1762
Intervention low IP N=1649
Control N=1558
Received surgery
T2/T3 rectal cancer
Intervention high IP N=2730
Intervention low IP N=2555
Control N=2519
Received surgery
T4/M0 rectal cancer <75yr
Intervention high IP N=241
Intervention low IP N=240
Control N=208
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Abstract 
Background
Treatment  variation is an important issue in health care provision. An external peer review 
programme for multidisciplinary cancer care was introduced in 1994 in the Netherlands to 
improve the multidisciplinary organisation of cancer care in hospitals. So far the clinical impact 
of external quality assessment programmes such as external peer review and accreditation 
remains unclear. Our objective was to examine the degree of variation in treatment patterns 
and the possible effect of external peer review for multidisciplinary cancer care for breast cancer 
patients.
Methods
Patients with breast cancer were included from 23 hospitals from two ‘intervention regions’ 
with the longest experience with the programme and 7 hospitals that never participated (control 
group). Data on tumour and treatment characteristics were retrieved from the Netherlands 
Cancer Registry. Treatment modalities investigated were: the completeness of breast conserving 
therapy, introduction of the sentinel node biopsy, radiotherapy after BCS for ductal carcinoma 
in situ (DCIS), adjuvant radiotherapy for locally advanced breast cancer (T3/M0 or any T,N2-
3/M0), adjuvant chemotherapy for early stage breast cancer (T1-2/N+/M0) and neo-adjuvant 
chemotherapy for T4/M0 breast cancer. Hospitals from the two intervention regions were 
dichotomised based on their implementation proportion (IP) of recommendations from the 
final reports of each peer review (high IP vs. low IP). This was regarded as a measure of how 
well a hospital participated in the programme.
Results
63516 female breast cancer patients were included (1990-2010). Variation in treatment patterns 
was observed between the intervention regions and control group. Multidisciplinary treatment 
patterns were not consistently better for patients from hospitals with a high IP.
Conclusions 
There is no relationship between the external peer review programme for multidisciplinary 
cancer care and multidisciplinary treatment patterns for breast cancer patients. Regional factors 
seem to exert a stronger effect on treatment patterns than hospital participation in external peer 
review.
67Variation in breast cancer treatment and the role of external peer review
Background
Breast cancer is the commonest cancer in women in the Netherlands and its burden increased 
during the last decades due to a steady rise in incidence [1]. Survival rates have improved because 
of better imaging and detection techniques, screening programmes and the introduction of 
new therapies [2, 3]. Breast cancer treatment is marked by a multidisciplinary approach and 
specialisation of the involved medical and nursing specialists. A recent study in 13,722 women 
showed that improving multidisciplinary care was associated with improved survival and 
reduced variation in survival among hospitals [4]. Specialisation of physicians is an important 
component of multidisciplinary care and is associated with better outcomes for various cancers 
[5]. A study in the UK revealed an 11-17% reduction in risk of death in women treated for 
breast cancer as a result of specialisation of surgeons [6]. Similar results were seen in other types 
of cancer and during the 90’s multidisciplinary care became the standard of cancer care. It is 
known that treatment variation exists between and within countries and it is unknown whether 
and how these differences interact with improvement efforts. This poses serious challenges in 
efforts to evaluate improvement programmes. 
Several quality improvement methods are used to improve the multidisciplinary organisation 
of care and reduction of variation. In the Netherlands an external peer review programme 
was introduced in 1994. Designed and executed by medical and nursing cancer specialists, 
it was introduced in the Northern Netherlands and gradually spread over the entire country. 
The programme focuses on the organisational conditions to provide optimal cancer care. 
Participation is voluntary and hospitals are advised to participate in cycles of 4-5 years. 
After a self-assessment, on-site observation and interviews, the organisation of cancer care 
in a hospital is evaluated and recommendations for improvement are given. Major topics of 
recommendations were the organisation of weekly multidisciplinary patient care meetings, 
shared decision making between specialists, oncological specialisation of medical specialists, 
dedication of oncology committees (with representatives of all medical specialisms) to policy 
making, referral policies for rare tumours and highly complicated interventions, introduction 
of integrated care pathways and working to evidence based guidelines. More information on the 
programme can be found in Additional file 1.
In general, the clinical impact of external peer review remains underinvestigated. A study 
evaluating a peer review programme for chronic obstructive pulmonary disease in the United 
Kingdom found an association with improved quality of care, service delivery and changes 
that promote quality improvement after three years [7]. The evaluation after one year revealed 
no differences showing that changes in healthcare can take a prolonged period to occur [8]. 
Accreditation is the most frequently studied form of external quality assessment. Literature 
reviews on the effects of accreditation on the quality of care could not provide strong evidence 
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due to limitations of the studies [9, 10]. The programmes demand high financial and labour 
investments and therefore there is a need for more research on the clinical impact of these 
programmes [11, 12].
The purpose of our study was to investigate the multidisciplinary treatment patterns of breast 
cancer patients and the effect of the external peer review programme for multidisciplinary 
cancer care in general hospitals. In a previous study we found some positive effects on colorectal 
cancer treatment, but the results needed to be interpreted cautiously due to the ambiguity of 
the outcomes and possible confounding factors [13]. In the current study we examined whether 
our previous results are also evident in breast cancer treatment. More importantly, by analysing 
different regions separately we hope to gain more insights in possible regional confounders. We 
hypothesised that the willingness of a hospital to have external peer review and to follow the 
recommendations from it, is correlated to the hospital giving higher quality of breast cancer 
treatment measured by the introduction of new multidisciplinary therapies. 
Methods
Design and patients
Only female patients diagnosed with primary epithelial breast cancer (ICD-O 10, International 
Classification of Diseases, codes: C50.0 to 50.9) between 1 January 1990 and 31 December 
2010 were selected from the Netherlands Cancer Registry (NCR). This is a population based 
independent cancer registry containing clinical administrative data of every newly diagnosed 
cancer patient in the Netherlands. Data is collected directly from the hospitals’ patient files by 
specially trained registration clerks. Topography and morphology is coded according to the 
International Classification of Diseases for Oncology (ICD-O) and staging according to the 
TNM-classification. Follow-up of vital status is achieved by linkage of the registry to municipal 
records. The quality of the data is high [14] and completeness is estimated to be at least 95% 
[15]. Patients were included from hospitals in the Northern Netherlands and the Rotterdam 
region. In these regions the external peer review programme was introduced first (intervention 
regions). Patients from hospitals from other regions that never participated before 2009 were 
included in the control group. We excluded patients that were diagnosed with neuroendocrine 
tumours, synchronous tumours, diagnosed at autopsy and that had any type of previous 
malignancy. 
Hospital categories
Hospitals from the intervention group were categorised by the implementation proportion (IP) 
of recommendations that were given in the final reports of each peer review. We dichotomised 
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the intervention region hospitals by their IP (high IP vs. low IP, no threshold was used). We 
regarded the IP of the recommendations as a proxy of how well a hospital participated in 
the programme. Rating the implementation was performed by studying final reports from 
subsequent reviews, follow-up correspondence, hospital documents and interviews with 
stakeholders when necessary. Implementation of a recommendation was ranked on a scale from 
0 to 4 (Table 1). The IP per hospital was expressed as a percentage of the total possible score. 
When implementation of a recommendation could not be determined (lost to follow-up), this 
recommendation was subtracted from the total possible score. The average IP of all peer reviews 
per hospital was used because it is not known what the time period is in which changes based 
on organisational change can occur and quality improvement is a continuous process. Ranking 
the implementation of recommendations was performed by the principal investigator. If e.g. the 
report from the next peer-review states that a recommendation was not implemented at all this 
was ranked as zero. Full implementation was ranked as 4, examples of recommendations and 
their ranking can be seen in Table 1. Due to the objective nature of the evidence the ranking was 
not considered to be arbitrary and we did not use an inter-rater approach.
Implementation 
score 
Criteria Recommendation Follow up report
0 Not implemented at all
1 Hospital only started working 
on implementing
The oncology committee should 
make oncological policy plans
An oncological policy plan is in 
preparation
2 A recommendation consists 
of two parts and one is 
implemented
An oncology committee needs to 
be formed consisting of physicians 
and a nursing staff representative
There is an oncology committee 
consisting of physicians but no 
nursing staff representative
3 Recommendation is imple-
mented but not yet in the 
entire organisation
There should be oncological 
specialisation, especially amongst 
the surgeons, urologists and gynae-
cologists
Oncological specialisation was 
realised in surgery, gynaecology, 
internal and pulmonary medicine 
but not in urology
4 Complete implementation The hospital should have a full-time 
pulmonary physician if lung surgery 
is performed for an optimal pre-, 
peri- and post-operative care
The hospital appointed a full-time 
pulmonary physician
Table 1. Criteria and (real) examples of the ranking of implementation of the recommendations on a scale from 0-4
From the hospitals in the two intervention regions we used data from two or three cycles of 
participation: 
- North Netherlands: three cycles, 1994-2009. 
- Rotterdam region: two cycles, 1996-2006. A third cycle was completed between 2009 and   
   2011 but follow-up time was too short to monitor the IP. 
All hospitals in these regions voluntarily participated in the peer review programme. The 
university medical centres and hospitals that merged during our study period were excluded, 
because it was impossible to follow-up the recommendations. Hospitals were asked to 
participate in the study by giving permission to use their data from the NCR and final reports.
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Analyses
We analysed the Northern Netherlands and Rotterdam region separately to gain more insights 
in possible regional confounders besides the external peer review programme. Patients were 
grouped according to the hospital in which the diagnosis was made. They may have been 
referred for treatment but this was regarded to be good clinical practice (and referral policy is a 
theme of the programme). Multivariate logistic analysis was used to analyse treatment variation 
and the influence of hospital category (based on IP), gender, age at diagnosis, year of diagnosis, 
average hospital volume of diagnoses and presence of an in-hospital radiotherapy department. 
We studied several multidisciplinary treatment modalities. First of all, we studied the completeness 
of  breast conserving therapy (BCT). From its introduction onwards, breast conserving therapy is 
a multidisciplinary procedure and one of the earliest examples of multidisciplinary cancer 
treatment. Breast conserving surgery (BCS) was initially complemented with axillary lymph 
node dissection (ALND) and radiotherapy. Omission of lymph node dissection is allowed 
after a negative sentinel node biopsy (SNB). In our analyses, BCT was considered complete if 
radiotherapy had been given and ALND was performed or when radiotherapy is given, SNB 
was performed and ALND was omitted. We separately analysed the introduction of  the sentinel node 
biopsy. Other indicators for treatment variation were taken from the indicator list of defined 
by the NABON (National Breast cancer Network Netherlands) in 2009. This list is part of a 
national audit on the quality of breast cancer diagnostics and treatment (NBCA) and started 
in 2011 [16]. These indicators are: radiotherapy after BCS for ductal carcinoma in situ (DCIS), adjuvant 
radiotherapy for locally advanced breast cancer (T3/M0 or any T,N2-3/M0), adjuvant chemotherapy for early 
stage breast cancer (T1-2/N+/M0) and neo-adjuvant chemotherapy for T4/M0 breast cancer. Although 
the NBCA was established in 2011 information on the selected indicators were available since 
1990. We could therefore look in retrospect at the period from 1990 onwards to evaluate how 
hospitals performed on these quality indicators that we now regard to be the standard of care 
for breast cancer patients.
For the analyses of completeness of breast conserving therapy and adjuvant chemotherapy 
for early stage breast cancer pathological stage was used and substituted with clinical stage if 
pathological stage was unknown. For the rest of the analyses clinical stage was used substituted 
by pathological stage if unknown. STATA version 12.0 was used for all analyses. Written syntaxes 
guarantee reproducibility of the results. P-values were considered significant if smaller than 0.05.
Results
Hospitals and recommendations
Twenty-six hospitals from the Northern Netherlands and Rotterdam region were asked to 
give permission to use the data from their peer reviews and the Netherlands Cancer Registry. 
Twenty-three gave permission: 13 hospitals from the Northern Netherlands and 10 from the 
Rotterdam region. Seven out of 12 hospitals without experience with the programme agreed 
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to be included in the control group. In total, our study includes patient data from 30 hospitals, 
approximately one-third of all hospitals in the Netherlands. In the three cycles of peer review 
in the Northern Netherlands and two cycles in the Rotterdam region 727 recommendations 
were given, averaging 12 recommendations per peer review per hospital. The intervention 
hospitals in both regions were dichotomised based on the IP of the recommendations. The 
Northern Netherlands region was divided in six hospitals with a high IP (average IP 63.2%) 
and seven hospitals with a low IP (average IP 48.9%). The Rotterdam region was dichotomised 
in five hospitals with a high IP (average IP 63.2%) and 5 with a low IP (average 41.4%). 
Patients
Our total cohort consist of 63 516 women. Table 2 shows the characteristics of the population 
grouped by their hospital category. There were no large differences in mean age at diagnosis 
and the number of patients per period of diagnosis between patients diagnosed in the different 
hospital categories. The average annual case volume differs between the regions, as in the 
Rotterdam region no hospitals with less than 50 patients diagnosed annually existed in the 
period under study. For only two hospital categories hospitals with more than 100 diagnosis per 
year existed (Northern Netherlands high IP and control group, Table 2). 
 
Variable
North High IP 
N(%)
6 hospitals
North Low IP 
N(%)
7 hospitals
Rotterdam High 
IP N(%)
5 hospitals
Rotterdam 
Low IP N(%)
5 hospitals 
Controls N(%)
7 hospitals
Mean age at diagnosis 61.16
SD 14.16
61.48
SD 14.20
61.33
SD 14.34
61.40
SD 14.39
59.80
SD 13.67
Period of diagnosis
1990-1995
1996-2001
2002-2007
2008-2010
3260 (23.21)
4079 (29.05)
4426 (31.52)
2278 (16.22)
2095 (19.42)
3085 (28.60)
3558 (32.98)
2050 (19.00)
2310 (23.16)
2717 (27.24)
3082 (30.90)
1866 (18.71)
2249 (23.28)
2635 (27.28)
3044 (31.51)
1732 (17.93)
4454 (23.38) 
5131 (26.93)
5995 (31.47)
3470 (18.22)
Stage
IS
1
2
3
4
X
1097 (7.81)
4758 (33.88)
5881 (41.88)
1480 (10.54)
718 (5.11)
109 (0.78)
776 (7.19)
3660 (33.93)
4575 (42.41)
1123 (10.41)
547 (5.07)
107 (0.99)
794 (7.96)
3323 (33.31)
4243 (42.54)
1018 (10.21)
513 (5.14)
84 (0.84)
775 (8.02)
3249 (33.63)
4097 (42.41)
959 (9.93)
487 (5.04)
93 (0.96)
1577 (8.28)
6595 (34.62)
7898 (41.46)
1835 (9.63)
877 (4.60)
268 (1.41)
Average annual volume 
of hospital of diagnoses
<50
50-100
100 or more
924 (6.58)
4226 (30.09)
8893 (63.33)
647 (6.00)
10141 (94.00)
0 (0.00)
0 (0.00)
9975 (100)
0 (0.00)
0 (0.00)
9660 (100)
0 (0.00)
953 (5.00)
16.579 (87.03)
1518 (7.97)
Table 2. Characteristics of breast cancer patients according to the hospital category, 1990-2010, data are no (%), 
N=63,516. IP= Implementation Proportion of recommendations given in the programme.
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Completeness of breast conserving therapy
Incomplete breast conserving therapy, omitting radiotherapy and/or ALND after breast 
conserving surgery rarely occurred (Table 3). Although the absolute risk is low, the odds ratio’s 
show that the risk of receiving complete BCT were higher in both hospital categories in the 
Northern Netherlands. 
Introduction of the SNB 
Since 2003 guidelines recommend the SNB to be performed in T1-2/N0 breast cancer. 
Unfortunately, the SNB was not registered consistently in the NCR in some regions of the 
country. When an ALND was performed after SNB then only the ALND has been registered 
in these regions. This might give an underestimation of the group that had a BCT with SNB 
followed by ALND. In our study, this only concerns the control group. We excluded all patients 
from the control group that were diagnosed in regions with this deviating registration policy 
(N=1950). The control group remained the largest group. Patients in the control region were 
more likely to receive a sentinel node biopsy compared to both intervention regions. The 
differences were most prominent between 1996-2001 (Table 3). 
Radiotherapy after BCS for DCIS
The total numbers of patients are low in the early periods. After the introduction of a nationwide 
screening programme the incidence of DCIS has gradually risen because of the increasing 
quality of diagnostics. In the latest time period the percentage of radiotherapy was over 79% 
in all hospital categories. No significant differences were seen between the odds for receiving 
radiotherapy in the different hospital categories (Table 3). 
Adjuvant radiotherapy for locally advanced breast cancer
Official guideline introduction of adjuvant radiotherapy for locally advanced breast cancer (T3/
M0 or any T,N2-3/M0), was in 2002 and a large variation existed before and afterwards (Table 
3). The control and Northern region hospitals with the highest IP show the best implementation 
of this recommendation of the guideline while especially before 2008 patients in the other 
regions were less likely to receive adjuvant radiotherapy. 
Adjuvant chemotherapy for early stage breast cancer
Patients diagnosed in hospitals in the Rotterdam region and Northern Netherlands with a low 
IP received adjuvant chemotherapy more often for early stage breast cancer than patients in the 
control hospitals (Table 3). Guideline follow-up in the later time-periods is high and differences 
between the different hospital categories are small.
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Neoadjuvant chemotherapy for T4/M0 breast cancer
Neoadjuvant chemotherapy for T4/M0 cancer is administered to approximately half of the 
patients in the latest time period (Table 3). Because this concerns high stage disease, patient 
preferences may play an important role in this variation. Both hospital categories in the 
Rotterdam region as well as the Northern low IP hospitals perform better compared to the 
control group, with the highest chance of receiving neoadjuvant chemotherapy in the Rotterdam 
hospitals with high IP (OR 2.67, 95% CI 1.74-4.07, Table 3).
Treatment Hospital 
category
% of patients treated according to 
guidelines 
OR 95% CI
‘90-‘95 ‘96-‘01 ‘02-‘07 ’08-‘10
Complete breast conserving 
treatment. N=22453
Inclusion criteria: Stage I-IIIA
Exclusion criterium: Breast amputation 
after BCS
Controls 
North High IP
North Low IP
Rotterdam High IP
Rotterdam Low IP
95.6
97.8
95.4
93.0
94.6
92.3
97.1
96.3
88.9
89.6
93.4
97.8
96.7
91.9
91.7
95.8
98.3
97.1
96.7
95.0
1.00
2.68*
1.77*
0.77*
0.72*
Reference
2.08-3.45
1.43-2.17
0.64-0.92
0.60-0.85
Introduction of the SNB.  N=25612
Inclusion criteria: cT1-2, cN0, cM0, BCS
Controls 
North high IP
North low IP
Rotterdam high IP
Rotterdam low IP
0
0
0
0
0
33.9
16.2
20.9
19.1
14.8
93.6
93.9
93.2
89.0
92.1
98.3
98.8
98.2
98.8
96.9
1.00
0.68*
0.59*
0.46*
0.48*
Reference
0.55-0.84
0.50-0.70
0.38-0.55
0.40-0.57
Radiotherapy after BCS for DCIS. 
N=2414
Inclusion criteria: DCIS, BCS
Controls 
North high IP
North low IP
Rotterdam high IP
Rotterdam low IP
16.1
50.0
57.1
33.3
27.6
31.7
49.0
43.7
48.9
50.4
76.8
74.8
72.5
72.0
74.1
85.2
84.9
81.7
79.8
83.3
1.00
1.24
1.13
1.08
1.27
Reference
0.88-1.74
0.84-1.52
0.79-1.49
0.93-1.73
Adjuvant radiotherapy locally 
advanced breast cancer. N=1511
Inclusion criteria: cT3, any N, M0 en 
any T, N2-3, M0 + amputation
Controls 
North high IP
North low IP
Rotterdam high IP
Rotterdam low IP
64.6
53.5
46.2
39.2
29.7
67.3
54.4
62.5
34.2
35.9
64.6
53.5
46.2
39.2
29.7
69.1
68.3
53.2
61.5
68.6
1.00
0.75
0.56*
0.40*
0.36*
Reference
0.51-1.10
0.39-0.80
0.29-0.55
0.25-0.52
Adjuvant chemotherapy early stage 
breast cancer. N=9511
Inclusion criteria: pT1-2 M0/X, surgery 
age<60
Controls 
North high IP
North low IP
Rotterdam high IP
Rotterdam low IP
51.3
62.3
52.8
60.2
55.3
73.1
69.7
70.6
72.3
67.2
85.1
90.4
91.4
88.0
90.1
91.9
93.0
91.3
95.6
96.0
1.00
1.24
1.29*
1.50*
1.22*
Reference
1.00-1.54
1.07-1.54
1.26-1.81
1.01-1.46
Neoadjuvant chemotherapy T4/M0 
breast cancer. N=1484
Inclusion criteria: cT4NxM0, surgery
Controls 
North high IP
North low IP
Rotterdam high IP
Rotterdam low IP
5.1
11.2
4.8
6.7
5.3
27.4
25.0
22.8
28.0
29.2
34.5
56.0
57.8
55.0
54.8
61.9
65.3
44.0
51.9
61.5
1.00
1.24
1.57*
2.67*
2.02*
Reference
0.73-2.09
1.00-2.47
1.74-4.07
1.32-3.08
Table 3. Odds ratio’s for receiving multidisciplinary therapy per hospital category. Adjusted for age, year of 
incidence, annual volume of diagnoses per hospital, stage (if necessary). 1990-2010 *P<0.05. IP= Implementation 
proportion of recommendations given in the programme.
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Discussion
The results of our study show variation in the multidisciplinary treatment of breast cancer 
patients in the Netherlands.  No relationship was evident between variation in multidisciplinary 
treatment for breast cancer patients and participating in the external peer review programme 
for multidisciplinary cancer care. In the Northern Netherlands, only the completeness of breast 
conserving therapy (stadium I-IIIA) was better in patients diagnosed in hospitals with a higher 
IP compared to the control group. Patients from hospitals with the lowest IP more often received 
adjuvant chemotherapy for early stage breast cancer, neoadjuvant chemotherapy for T4 breast 
cancer and complete breast conserving therapy. In the Rotterdam region, patients diagnosed 
in hospitals with the highest IP were more likely to receive neoadjuvant chemotherapy for T4 
breast cancer and adjuvant chemotherapy for early stage breast cancer. The latter results also 
account for patients from hospitals with a low IP from the Rotterdam region when compared 
to the control group. Differences between the regions imply that there are regional factors that 
are responsible for the variation.  
Before 2002, there was regional variation in guidelines. Table 3 shows that variation decreased 
in the periods from 2002-2007 and 2008-2010 but no early adopter effect was seen in patients 
from hospitals with a higher IP. A previous study by van Steenbergen et al. on early stage 
breast cancer also showed decreased variation after the introduction of national evidence-
based guidelines in 2002 but variation still persisted. Differences could be partly explained by 
hospital characteristics but also by locoregional practices. Adjuvant systemic therapy was found 
to be mainly influenced by patient and tumour characteristics [17]. Another study on early 
stage breast cancer confirms the important role of the national evidence-based guidelines and 
identified age as the most important factor in the decision whether a patient receives systemic 
therapy. They also found the presence of early and late-adopters amongst hospitals but could 
not determine the role of physicians or hospital characteristics [18]. The programmes in the 
Northern Netherlands and Rotterdam region were similar in origin. During the second cycle 
in the Rotterdam region, the focus shifted from the evaluation of basic organisational topics to 
implementing plan-do-check-act cycles and the measurement of quality within hospitals. This 
shift also occurred in the North region but the basic organisational topics remained part of the 
programme.
The main weakness of our study was that we had to use a black box approach concerning the 
supposed mechanism through which external peer review on hospital level exerts its influence 
on tumour service levels. Moreover we did not have the possibility of correcting possible 
confounding factors such as co-morbidity and patient preference. The gradual spread of the 
programme over the country gave us the possibility to use a control group, creating a quasi-
experimental situation. Hospitals in the control group are likely to have introduced changes 
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in their organisation too, but we are not aware of similar programmes that have been used. 
Hospitals from the high IP and low IP groups may have had different starting points concerning 
organisational quality, unfortunately we did not have a baseline measurement of organisational 
quality. Therefore, we can not answer the question if hospitals that already had a good 
multidisciplinary organisation also performed well on implementing the recommendations 
from the programme. 
Research in this field is challenging. Besides the ‘quasi-experimental’ situation (due to the 
gradual introduction of the programme) our study had multiple characteristics that helped 
us to evaluate the impact of external peer review. In the intervention regions all hospitals 
participated in the programme (even though they did not all give permission to use their data 
in this study). Because of this, there was no programme participation bias. We did not rank 
the importance of recommendations to assess the programme impact instead of the impact 
of single recommendations. We were able to analyse results on a ‘patient level’ because of the 
reliable and complete data, including information on treatment, over a long period of time 
provided by the Netherlands Cancer Registry. 
Conclusion
Our study showed regional differences and did not reveal benefits in the multidisciplinary 
treatment of breast cancer patients being treated in hospitals participating in the programme 
nor did the extent in which the hospitals implemented the recommendations seem to matter. 
Organisation focussed quality improvement programmes are generally not designed to directly 
improve clinical care and in methodological terms this can still be considered as a “black box 
intervention”. Improving the organisation of care seems a justified goal, but it may be questioned 
whether the effort put into it is justified if no clinical benefits can be shown. If the objective 
is that external quality assessment programmes should have a measurable effect on clinical 
outcomes, the programmes should change their approach. A better focus on the actual delivery 
of clinical care and incorporating reliable outcome data (from cancer registries) can bridge the 
gap between quality improvement and patient outcomes. Variation in treatment, as shown in 
our study can be used as a starting point for quality improvement programmes for hospitals to 
work on their organisation and delivery of care.  
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Additional file 1
The external peer review programme for multidisciplinary cancer care.
Organisation of cancer care requires agreements between physicians, nursing staff, patients 
and all others involved. The external peer review programme for multidisciplinary cancer 
care covers the aspects of care which can be agreed upon to guarantee a high quality of care. 
This does not concern the actual clinical care but prerequisites that apply to the cancer care 
organisation. The programme relies on a ‘quality framework’ which describes requirements of 
three main aspects of care:
- Policy and organisation: organisational aspects of the hospital itself: internal regulations, 
means and materials, external cooperation.
- Management of processes: matters concerning the process that a patient undergoes. For 
example: shared decision making and exchange of information between providers, referral 
policies, time till treatment, informational and educational materials. 
- Quality control system: the evaluation and actualisation of the quality control system and 
measures for improvement.  
Concerning clinical care: the quality framework describes the requirement of up-to-date 
guidelines for the treatment of cancer patients. During the external peer review there is no 
check on an individual patient level if patients received the appropriate treatment. However, 
cancer registry data is used to evaluate e.g. the use of adjuvant treatments on a hospital level 
(compared to national averages).
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Abstract
Background
External peer review was introduced in general hospitals in the Netherlands in 1994 to assess 
and improve the multidisciplinary team approach in cancer care. This paper aims to explore the 
value, perceived impact and (future) role of external peer review in cancer care.
Material and methods
Semistructured interviews were held with clinicians, oncology nurses and managers from 
fifteen general hospitals that participated in three rounds of peer review over a period of 16 
years. Interviewees reflected on the goals and expectations, experiences, perceived impact and 
future role of external peer review. Transcriptions of the interviews were coded to discover 
recurrent themes.
Results
Improving clinical care and organization were the main motives for participation. Positive 
impact was perceived on multiple aspects of care such as shared responsibilities, internal 
prioritization of cancer care, improved communication and a clear structure and position of 
cancer care within general hospitals. Establishing a direct relationship between external peer 
review and organisational or clinical impact proved to be difficult. Criticism was raised on the 
content of the programme being too theoretical and organization-focussed after three rounds. 
Conclusions
According to most stakeholders, external peer review can improve multidisciplinary team work 
in cancer care; however the acceptance is threatened by a perceived disbalance between effort 
and visible clinical impact. Leaner and more clinically focused programmes are needed to keep 
repeated peer reviews challenging and worthwhile. 
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Introduction
Multidisciplinary team (MDT) work has become the standard in cancer care in the last 
decades as diagnostic and treatment options for various cancers grew.1 The importance of 
multidisciplinarity further increased due to a shift from disease-focused management to a 
patient-centered approach. The European Partnership for Action Against Cancer (EPAAC), 
launched by the European Commission in 2009, therefore identified multidisciplinary care 
as a key element in cancer care.2 Evidence on the impact of MDT-work on clinical outcomes 
is sparse, partly due to difficulties in relating procedural and organizational changes to the 
various possible benefits.3 A recent study in 13722 breast cancer patients showed that improved 
multidisciplinary care was associated with improved survival and reduced variation in survival.4 
While MDT-work may seem self-evident for specialized cancer centres or university hospitals, 
it is a more recent development and an organizational challenge for general hospitals.5 
In the Netherlands, regional Comprehensive Cancer Organisations were established in the 
eighties to disseminate specialized knowledge on cancer diagnosis and treatment and to 
improve service provision without having a treatment function themselves. They formed 
networks of healthcare professionals with the aim to improve cancer care and outcomes through 
research, guideline development and implementation, knowledge exchange and organizational 
improvement, for instance by promoting multidisciplinary care. The Comprehensive Cancer 
Organisation in the North of the Netherlands introduced an external peer review programme 
in 1994 to review the multidisciplinary organization of cancer care in hospitals and provide 
relevant feedback for further improvement. The programme focussed on the organization of 
cancer care within the general hospital setting. Over time, it evolved and also paid attention to 
patient centeredness and important (inter)national trends such as centralization. The primary 
focus remained on the organization of cancer care and the functioning of the multidisciplinary 
teams. Policies were reviewed but not checked for individual cases, such as compliance 
with policies for adjuvant chemotherapy or psychosocial care. Through self-reviews, site-
visits and on-site interviews the organization of cancer care in a hospital is evaluated and 
recommendations for improvement are given. Reviewers are specially trained clinicians and 
nurses from other hospitals. Hospitals participate voluntarily and are advised to participate in 
cycles of four to five years to ensure continuous cycles of quality improvement. Annex 1 gives 
more detailed information on the external peer review programme. Similar programmes have 
been introduced in other countries. In England, for example, National Cancer Peer Review 
(NCPR) was introduced as part of the National Cancer Programme in 2004, after a first round 
of peer review was conducted at a regional level in 2001.6 The English programme focuses on 
performance for specific tumour groups, whereas the Dutch programme primarily targets the 
multidisciplinary cancer care organization in hospitals as a whole. 
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Until now, we have published two peer-reviewed studies on the effects of the Dutch peer 
review programme for multidisciplinary cancer care.7,8 Some positive effects were found on 
multidisciplinary colorectal cancer treatment but the outcomes needed to be interpreted with 
care due to possible confounding factors such as patient casemix and regional differences.7 
No added value was found on multidisciplinary treatment of breast cancer, as regional factors 
seemed to exert a stronger effect on treatment patterns than hospital participation in external 
peer review.8 In general, (international) evidence on the effects of peer review on cancer care is 
sparse. In lung cancer, peer review was successful in stimulating quality improvement activities 
but improvements in treatment rates and patient experiences were small.9 Outside the field 
of cancer care, two studies report on the one- and three-year evaluation of peer review for 
chronic obstructive pulmonary disease in the UK.10,11 Findings after three years indicated an 
association with improved quality of care, service delivery and changes that promote quality 
improvement.11 The one-year evaluation revealed no differences showing that changes need a 
longer period to occur.10 
While evidence on external peer review is sparse, physicians worldwide are increasingly 
confronted with programmes such as external peer review and accreditation. In this qualitative 
study we aim to explore the role and impact of external peer review for multidisciplinary cancer 
care in the general hospital setting. In interviews with stakeholders we evaluated the value, 
perceived impact and (future) role of external peer review in cancer care.
Material and Methods
Semistructured interviews were conducted with stakeholders from general hospitals from 
two regions in the Netherlands that participated three times between 1994-2010 (North 
and Rotterdam region). The hospitals in these two regions have the longest experience in 
the programme with three cycles of peer review in our study period. We excluded hospitals 
that merged in the study period, as this made it hard to reflect on recommendations and 
the impact of the programme. From the two regions, all 26 qualifying hospitals were invited 
to participate in our study. Per hospital we requested to interview a clinician involved in 
the treatment of cancer patients, an oncology nurse and a representative from the board of 
directors or management. We aimed to interview at least two stakeholders per hospital. 
The following inclusion criteria were applied: (1) the interviewee was required to have 
participated in at least one peer review visit (preferably also involved in preparations for 
the programme); (2) oncology nurses should have coordinating/organizational tasks; (3) 
the management representative had to be involved with cancer care management in the 
hospital. Participation in the interviews was voluntary and participants were not reimbursed.
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The telephonic interviews were conducted in Dutch from May to October 2012 by the principal 
investigator (MK). Participants were informed about the purpose of the study and how the data 
would be used. The interviews followed a fixed scheme. First, the motivation for participation 
was discussed, followed by the experiences with the programme. This was discussed according 
to the chronological phases of the programme: self-review phase, the actual site-visit and the 
aftermath. Consequently, the impact was discussed and examples of programme effects were 
asked. To conclude, views on the role of the programme in the future and possible improvements 
were asked. A list of general questions covering these topics was used. An overview of the 
main interview topics, questions and the rationale behind the questions is presented in Table 1.
Interview topics Main/Opening question(s) Rationale
Goals What are your goals for participation in this 
programme?
Explore if the incentive is organizational improve-
ment, quality improvement or both.
Experiences
(programme 
evaluation)
What are your experiences with the self-as-
sessment phase of the programme and what 
was its value?
What are your experiences with the actual 
site-visit, what was its value and what was 
the added value after the self-assessment?
What is your opinion about the end-rapport, 
did it reflect the state of cancer care in your 
hospital?
Experiences with the different programme phases 
gives information on what the most important parts 
of external peer review programmes are and when 
changes occur.
Impact In which areas did you experience a pro-
gramme impact? 
Can you give examples of programme 
effects?
Answers give insights in how external peer review 
influences organization and care and which aspects 
of care are affected. 
Future If the programme would remain as it is now, 
would you participate again?
How can the programme be improved?
Does a programme retain its value after three partici-
pations or does it need changes?
All interviews were recorded and transcribed verbatim using word processing software by the 
principal investigator (MK). All data were anonymized and interviewees were guaranteed that 
data would not be shared with third parties, allowing them to speak freely. The transcripts were 
analysed by using ATLAS.ti software (version 7, www.atlasti.com). Using an inductive approach 
(organizing the data based upon common patterns or themes), the entire transcripts were coded. 
Answers were given a distinct code to get an overall impression of the results from the interviews. 
Relevant citations were selected as illustration per interview topic. The results and citations 
were discussed with other investigators (WVH, SS). Despite the qualitative nature of this study, 
answers on specific questions, such as what the goals were to participate could be quantitatively 
analysed. In these cases, frequencies of answers were used to determine their relative importance. 
Table 1. Overview of interview themes with examples of questions and the rationale behind the themes and 
questions. In this table only the main ‘opening questions’ are presented.
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Results
Study population
Fifteen out of the twenty-six invited hospitals participated in our study. Two hospitals reacted 
that they were either not able or not willing to invest their time in the interviews, the rest did 
not reply to our invitation and gave no reason for not participating. In our study population of 
15 hospitals, it was not possible to interview two stakeholders in two hospitals; in one hospital 
we could only interview a medical specialist and in another hospital we only interviewed an 
oncology nurse. Additionally, in one hospital there was not a nurse available with sufficient 
experience with the programme to participate. We could only interview four managers that met 
our criteria of being personally involved in at least one external peer review and involvement 
in cancer care (partly due to high management turnover). In total, data from 15 hospitals 
and 31 interviews were analysed: 14 physicians (eight medical oncologists, four surgeons, 
one pulmonary physician and one gynaecologist), 13 oncology nurses and four management 
representatives.
Interview Findings
Motivation
The motivation to participate could be coded into ten distinct codes or ‘buckets’ as can be seen 
in Table 2. We further categorized these codes into four main ‘themes’. The most frequently 
mentioned goal for participating in the programme was to obtain feedback on the quality of 
organization and processes (coded 21 times). Clinical quality improvement is mentioned by 
a majority of interviewees (N=19) as a goal for participation, even though the programme 
foremost has an organizational focus. Differences between physicians and nurses are seen in the 
positioning of cancer care which is an important goal especially for physicians (physicians: eight, 
nursing staff: two). By the position of cancer care the interviewees mean that cancer care was 
given priority amongst a hospital wide range of services and became the joined responsibility 
for physicians, nursing staff and management. This is illustrated by the next quote:
“As a medical oncologist you are not the only one in the web of physicians surrounding a 
patient. In every single case, a lot of physicians should communicate and cooperate. Sometimes 
one physician thinks this is more important than another. By participating in the programme 
you hope that attention is raised for everyone to see this necessity.” [Oncologist]
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Goals/incentive for 
participation 
(themes)
Goals mentioned by interviewees  Physicians
(N = 14)
Nurses
(N = 13)
Management
(N = 4)
Total
(N = 31)
External motivation Transparency 1 4 0 5
Obligation 1 2 2 4
See what external experts find important 
in cancer care
0 4 0 4
Organization of care Quality test of organization and processes 
(see how well you are doing)
9 10 2 21
Positioning of cancer care in the hospital 
(priority for management and/or physi-
cians)
8 2 0 10
Reveal organizational weaknesses (blind-
spots)
0 4 0 4
Receive recommendations for improve-
ment
2 2 2 6
Re-evaluate existing patterns in coopera-
tion and communication
1 1 0 2
Clinical cancer care Quality improvement of clinical cancer 
care
9 7 3 19
Future perspectives Getting ready for changes in the future 1 0 1 2
Table 2. Number of times a goal for participating in the peer review programme was mentioned by different 
stakeholders. Interviewees could have had more than one goal.
Programme experiences
The first phase of the external peer review, the self-review phase, forced stakeholders to review 
the organization and cooperation within their own hospital. Nineteen respondents stated that 
self-review through stating compliance to lists of organizational standards is a good method 
to discover weak points in their organization. It was said that changes already occurred in this 
preparation phase as existing policies were revised and corrected if necessary. Interestingly, all 
of these nineteen interviewees claim that the weaknesses were not totally unknown beforehand. 
The self-review phase was also the most criticised part of the programme. All interviewees 
answered that the investments (time and effort) were high. The questionnaires were criticised 
for being too theoretical, insufficiently suited for their individual situation and containing 
too many irrelevant and ‘obvious’ questions. It was mentioned three times that difficulties in 
answering questions sometimes resulted in giving ‘desired’ answers. 
The actual site visit by peers, is valued highly, 20 respondents mentioned that this is the most 
important part of the programme. Especially the dialogue and opportunity to explain how 
they work was appreciated instead of only stating their compliance to a theoretical framework. 
Also, misinterpretations of answers given in the self-review could be corrected. Almost all 
interviewees (N=29) stressed the importance of a committee consisting of peers because of the 
mutual understanding of problems that hospitals are faced with. Eighteen participants think 
that the composition of the review committee (three medical specialists and one oncology 
nurse) does not need to be altered. Suggested changes to the committee were to add an extra 
88 Chapter 5
oncology nurse (N=2), a manager (N=2) or a professional from the psychosocial field (N=6). 
The rest of the interviewees had no opinion on this matter.
The final phase of the programme starts with the end-report based on the self-assessment and 
findings of the site-visit. The recommendations in the reports are generally regarded as a good 
reflection of the weaknesses and improvement points of the organization. All respondents 
answered that the recommendations are used in the cancer policy plans of their hospitals for 
the upcoming years. The reports are used to strengthen the position of the oncology services in 
negotiations with the board of directors and medical staff.
Perceived impact and examples of programme effects
In order to gain more understanding of how the programme impacted cancer care in hospitals, 
every stakeholder was asked to give examples of important effects of the programme (if there 
were any). We coded the aspects of care that were influenced by the programme. We found ten 
aspects of cancer care on which the programme had a perceived impact. They are mentioned in 
Table 3 with the examples that were given by the interviewees. The frequencies of the answers 
give a sense of importance but because we asked for examples we did not use the frequencies 
to determine which aspect of care is most influenced by the programme. Not mentioning an 
example does not mean that the programme did not impact that aspect of care in their hospital. 
A perceived impact on the position of cancer care within the hospital organization is expressed 
nine times. It was also mentioned ten times as goal for participation (Table 2). This seems to 
work two ways: as mentioned earlier, the participation itself creates attention and involvement. 
Secondly, the other examples of perceived impact also enforce prioritization of cancer care. 
For example, a perceived impact on the (role of the) oncology committee was expressed 21 
times in total. Also, according to a total of nine interviewees the role of the committee within 
the hospital and policy making was formalized. The formation of multidisciplinary oncology 
committees with representatives from all disciplines that treat cancer patients was stimulated 
especially in the first review rounds (most of the committees were small and not all disciplines 
were represented). This created an official structure within hospitals to advocate the interests of 
medical personnel and cancer patients in structural meetings with the board of directors and 
medical staff. Because the oncology committee was required to consist of representatives from 
all specialisms that treat cancer patients, ‘smaller specialisms’ like gynaecologists and urologists 
became more involved which improved communication. There was also a more general perceived 
impact on the cooperation between physicians and between physicians and nursing staff (N=4). 
Concerning clinical care, most impact was experienced on the multidisciplinary patient care 
meetings. Fourteen interviewees mentioned an example of impact on these meetings. Due to 
the recommendations, multidisciplinary patient care meetings were professionalised, protocols 
were developed on which patients should be discussed in these meetings and reporting was 
standardized. The programme required weekly meetings where every newly diagnosed cancer 
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Table 3. Examples of effects of the external peer review programme as mentioned by interviewees (N=31) grouped 
per theme
patient was discussed in the multidisciplinary team to improve shared decision-making. Less 
frequently mentioned examples of programme impact concern impact on structure, delivery 
of care, psychosocial care, nursing staff, referral policies and future perspectives. These 
include increased numbers of staff, better integration of psychosocial care and advice on the 
introduction of integrated care pathways (Table 3).
Theme Examples of impact given by the interviewees
Position of cancer care in hospital - cancer care became a priority (N=9)
Oncology committee - large committees were formed with representatives from all disciplines  
 treating cancer patients (N=9)
- role of committee was officially established in hospital organization (N=2)
- committee got responsibility for policy making (N=5)
- functioning of committee improved (N=3)
- structural meetings were organised with board of directors and medical 
 staff (N=2)
Cooperation - involvement of “smaller” disciplines such as gynaecologists and 
 urologists (N=6)
- improved communication between specialists and between specialists and 
 nursing staff (N=4)
- improved communication with general practitioners (N=1)
Multidisciplinary patient care meetings - involvement smaller disciplines in the meetings (N=3)
- protocols on which patients have to be discussed (N=14)
- uniformity of reporting (N=1)
Structure - increased number of nursing staff (N=6)
- investments in ICT (N=1)
Delivery of care - advice on the introduction of integrated care pathways (N=2)
- concentration of chemotherapy administration within the hospital (N=1)
Referral policies - referral policies were made for rare tumours (N=1)
- official agreements were signed with other hospitals on which patients to 
 treat and which to refer for further treatment (N=3)
Nursing staff - introduction of specialized oncology nurses (N=6)
- education (N=2)
Psychosocial care - increased number of psychosocial staff (N=6)
- clarity on the role and positioning of psychosocial staff (N=1)
- introduction psychosocial protocols (N=1)
Readiness for change - organization is better prepared to adapt to future changes (N=4)
Interviewees found it difficult to single out the effects of the programme. Investments in 
extra oncology nurses can be contributed to clear recommendations in the final reports of 
the programme, but other (clinical) effects of the program do not stand on their own. This is 
illustrated in the next citation: 
“Every patient has an individual case-manager now. That would probably have been established 
anyway, but because of the recommendation of the programme it might have been introduced 
earlier. Yes, I think that had an impact. Another example is the multidisciplinary patient 
care meeting. They needed to be held more often and larger groups of patients needed to be 
discussed. I think that this would have been realised anyway because of the national guidelines 
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and not only because of the programme, but it certainly influenced it.”[Oncology nurse]
Future role and improvements of the programme
All hospitals in our study population participated in three review rounds. The programme 
started with a strong focus on basic organizational requirements and evolved from there with 
more emphasis on professional quality and care pathway organization. The organizational focus 
remained to be a source of frustration. Twenty interviewees expressed their concerns on having 
to repeat all the organizational items in the self-review and site-visit in a fourth participation 
round. As a result, only 12 persons would still find a fourth participation worthwhile without 
major changes in the programme. This suggests that a mismatch between the investments and 
experienced benefits is a potential pitfall for the programme. 
Suggestions for improvement that were given are:
- move beyond the basic organizational conditions and focus on the actual delivery of   
                care
- decrease the time investments needed for self-review
- more emphasis on current and future requirements in oncology
- focus on one or two specific types of cancer
- give hospitals the opportunity to indicate on which parts of the care process they   
                would like to receive in-depth feedback
- strengthen the patients’ perspective compared to the organizational perspective.
Opinions varied whether the focus of the programme should remain on the entire cancer 
care organization or on specific types of cancer. Advantages mentioned of a tumor-specific 
programme were a better focus on actual care, less time-consuming preparations and the 
possibility to assign clinical experts as reviewers.
Disadvantages of a tumor-specific programme were also mentioned. There are already 
multiple organizations that have developed registrations and clinical audits for specific 
diseases. Because of this, there is a risk of an overkill of external assessment programmes. 
Other interviewees mentioned that the necessity to look at the entire organization does 
not change; weak points in the organization mostly concern aspects of cooperation and 
communication, which can be easier tackled through an organization focussed programme. 
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Discussion
It can be carefully concluded that the external peer review programme for multidisciplinary 
care in the Netherlands had a perceived positive impact on several aspects of cancer care. 
Most frequently mentioned were the internal positioning of cancer care, formation and role 
of oncology committee and multidisciplinary team meetings. Part of the experienced impact 
could be attributed directly to the programme based on recommendations in the final reports. 
Interviewees were hesitant to attribute more clinically oriented effects to the programme 
alone, as many factors can be of influence. Although the programme has an organizational 
focus, improvement of clinical care is mentioned as a motivation to participate almost as 
often as organizational improvement. Criticism was also raised, particularly on the repeated 
organizational focus and missing links with clinical care (most outspokenly in the self-review 
phase). Nineteen interviewees mentioned that while the self-review uncovers organizational 
weak spots, they were not entirely unknown beforehand. It therefore seems that the value 
lies in directing attention to these weak spots. The actual site visits were regarded as the most 
important part of the programme because of the dialogue that occurs with their peers from the 
review committee.
It is difficult to prove a direct impact of external quality improvement programmes. A previous 
mixed-method study on accreditation also struggled to answer the question. Performance on 
accreditation was found to be an accurate reflection of contextual organizational factors believed 
to be important in enabling or inhibiting quality of care and continuous quality improvement.12 
A French study on the impact of accreditation used a hypothetical model in which accreditation 
is seen as an agent of change.13 These studies complement our findings that external peer review 
is one of multiple factors that initiates change and contributes to a better organization that can 
lead to quality improvement.
The external peer review programme for multidisciplinary cancer care was introduced to 
strengthen and support the (introduction of) multidisciplinary team work. There are two main 
categories of barriers to effective cancer care coordination. Firstly, those barriers that are a result 
of an ineffective team (recognition of health professional roles and responsibilities, transition 
of care, inadequate communication) and secondly barriers that are the result of inadequate 
resources, including managing scarce resources and inequitable access to health services.5 
Our results especially show a perceived programme impact on those barriers resulting from 
ineffective team work. Examples of the perceived impact revealed a transferral of responsibilities 
from individual physicians to multidisciplinary teams consisting of physicians, nursing and 
supporting personnel. This lead to prioritization of cancer care, improved communication and 
a central position of cancer care within general hospitals. 
Contrary to our finding that the site-visit is the most valued part of the programme, previous 
research identified the self-review as the most important.13 This might be due to the fact that 
the review committee consists of peers which creates mutual understanding. It also implies that 
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stakeholders value an approach that is not overly focussed on standards. Touati and Pomey 
described this earlier and drew parallels between accreditation and a management model 
of “commitment based management” in stead of ‘control based management’.14 Leaving a 
philosophy of control and adapting a philosophy of commitment provides greater room for 
autonomy and creativity of the reviewed hospital and stakeholders. This approach to quality 
management requires a challenging balance of improvement dynamics with standardization and 
assurance, but can be used to prevent the perception of external quality assessment programmes 
as coercive tools of over-standardization.15 The disbalance between effort and effect threatens 
the legitimacy of the programme. Possibilities for improvement of the programme are mainly 
to move away from basic organizational requirements after a first or second round and focus 
more on actual clinical care. This can be achieved by making better use of the information from 
previous peer reviews. When it has been established that the basic organizational requirements 
were met, new peer reviews can pay attention to other aspects of care. This might create leaner 
and more flexible programmes.
Our study has several limitations. There will always be a certain degree of interpretation 
when working with qualitative data. We tried to minimize this by coding the transcripts with 
specialized software. The frequencies are mentioned to give a sense of importance. We were 
cautious to use this to make statements on the impact of the programme. The frequency counts 
in Table 2 and 3 are unbalanced which makes it difficult to draw firm conclusions. It does give a 
general overview of motivation and perceived impact. Although we interviewed representatives 
from 15 different hospitals, a larger study population might have revealed more details 
(although we experienced a considerable degree of saturation). We could only interview four 
management representatives due to a high management turnover and because managers were 
not always involved in the process before the actual site-visit. Eleven hospitals that were invited 
did not participate which might have resulted in a selection bias. The hospitals were invited 
because their regions were the first to implement the programme. Therefore, our findings only 
represent hospitals with multiple participations in the programme. The interviews were not 
done after each peer review but retrospective after three cycles of review which might cause 
a fading of memories. Hospitals that participate for the first time might find it more useful to 
focus on more basic organizational conditions. However, our research is unique in investigating 
organisations with multiple participations and our results show a decreasing acceptance for 
external peer review if a programme keeps focussing on organizational standards. 
Conclusion
Organizational external peer review can be an appropriate method for general hospitals to 
improve multidisciplinary team work in cancer care. In general hospitals, it can help in the 
internal positioning of cancer care and to improve structures and processes that encourage 
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multidisciplinary team work. Our findings suggest that, concerning actual clinical care, external 
peer review has an indirect impact by influencing the multidisciplinary patients meetings, 
numbers of staff etc. The acceptance of a programme that primarily focuses on organizational 
requirements decreases after multiple participations. As a majority of interviewees participate 
to improve both organizational and clinical care we argue that moving from an organizational 
focus to clinical cancer services in future participations can keep external peer review 
worthwhile and challenging.
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Abstract
Background
To improve quality of care, centralization of cancer services in high-volume centres has been 
stimulated. Studies linking specialization and high (surgical) volumes to better outcomes already 
appeared in the 1990s. However, actual centralization was a difficult process in many countries. 
In this study, factors influencing the centralization of cancer services in the Netherlands were 
determined.
Material and methods
Centralization patterns were studied for three types of cancer that are known to benefit from 
high surgical caseloads: oesophagus-, pancreas- and bladder cancer. The Netherlands Cancer 
Registry provided data on tumour and treatment characteristics from 2000-2013 for respectively 
8037, 4747 and 6362 patients receiving surgery. By plotting timelines of centralization of 
cancer surgery, relations with the appearance of (inter)national scientific evidence, actions of 
medical specialist societies, specific regulation and other important factors on the degree of 
centralization were ascertained. 
Results
For oesophagus and pancreas cancer, a gradual increase in centralization of surgery is seen 
from 2005 and 2006 onwards following (inter)national scientific evidence. Centralization steps 
for bladder cancer surgery can be seen in 2010 and 2013 anticipating on the publication of 
norms by the professional society. The most influential stimulus seems to have been regulations 
on minimum volumes. 
Conclusion
Scientific evidence on the relationship between volume and outcome lead to the start of 
centralization of surgical cancer care in the Netherlands. Once a body of evidence has been 
established on organizational change that influences professional practice, in addition some 
form of regulation is needed to ensure widespread implementation.
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Introduction
Centralization of low-volume cancers and high-risk surgical procedures is a frequently 
studied organizational quality issue, especially in surgical oncology. The first volume-outcome 
relationship in surgery was described in 1979 by Luft et al (1). In the following decades 
numerous studies have addressed the question whether higher surgical volumes result in an 
increased quality of care (2). Many of these studies concerned cancer surgery and a large body of 
evidence developed in favour of centralization of surgical procedures such as pancreatectomies 
and oesophagectomies (3). In general, a higher volume of surgery is associated with lower post-
operative mortality and morbidity (2, 4, 5). Nevertheless, in the Netherlands, referral patterns 
for pancreatic and oesophageal cancer remained largely unchanged up to the early 2000’s, 
despite a lively debate on the introduction of minimum surgical volumes (6). 
There may be several reasons why centralization was not directly embraced as a method to 
improve cancer care. The quality of the scientific evidence was questioned as many early 
studies were observational and not hypothesis driven and few studies actually investigated 
quality improvement after centralization (5). Possible differences in casemix restricted the 
generalizability of the available scientific evidence to the Dutch healthcare situation (as most 
studies were performed in the Unites States). As with any new treatment or technology there is 
a diffusion period before it becomes widely implemented. For example, a Dutch study on the 
dissemination of the sentinel node biopsy in breast cancer revealed a gradual increase over the 
course of five years (1998-2003)(7). There is still debate on volume thresholds, ceiling effects 
and the exact mechanisms through which quality is improved, though at present only a few 
question the need to centralize low volume and high-risk or complex procedures. Centralization 
of services is a delicate issue as professional pride and material interests could play a role in the 
debate and consequent decisions.
The first Dutch scientific evidence for a positive volume-outcome relationship in pancreas and 
oesophagus surgery was published by Gouma et al. in 1997 & 2000 and by van Lanschot et 
al. in 2001 (8-10). Wouters et al. showed reduced postoperative morbidity and mortality after 
centralizing oesophageal resections between 2000-2004 (11). In 2003, the Dutch Healthcare 
inspectorate started a new supervision policy based on publicly reported quality indicators 
including total number of surgeries for low volume tumours (12). The first form of regulation 
started in 2006 when the Healthcare Inspectorate (IGZ) banned oesophageal resections from 
hospitals with an annual surgical volume lower than 10. This number was also advised for 
pancreatic resections but not officially regulated. In 2010 the ‘quality of cancer care’ report 
was published by the Dutch Cancer Society (13). In this report, centralization of low-volume 
tumours and high-risk procedures was regarded to be one of the main strategies to reduce 
variation in outcome. The Healthcare Inspectorate insisted that in 2011 all medical specialists 
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societies published minimum volume standards (insisting on minimum volumes of 20 
operations per year) for highly complicated procedures and regulation would follow from 2013 
onwards. In 2011 the Association of Surgeons in the Netherlands (ASN) increased the minimum 
annual number of low-volume high-risk operations to 20. In 2012, the Dutch Federation of 
Oncological Societies (in Dutch: SONCOS, consisting of the Dutch Associations for Surgical 
Oncology (NVCO), Medical Oncology (NVMO) and Radiotherapy and Oncology (NVRO)) 
set minimum volume standards for the treatment of several types of cancer (14). In recent 
years, insurance companies started to use these thresholds for contracting policies adding an 
extra stimulus to the centralization debate. 
It is unknown whether and which professional, organizational and regulatory stimuli are most 
effective in stimulating centralization. Studying this might also provide a more general insight 
in what drives quality related organizational change in cancer care. We performed a nationwide 
analysis on the centralization of oesophagus, pancreas and bladder cancer surgery. Oesophagus 
and pancreas cancer are the most frequently studied types of cancer in relation to the volume 
of surgery. Bladder cancer is likely to benefit from centralization but minimum thresholds 
were not established in the Netherlands until 2010 (15-18). We hypothesize that even though 
centralisation of surgery will occur voluntarily and gradually based on scientific evidence, the 
most important factor for widespread centralization is official regulation. 
Materials and methods
Population
Data on all patients that were diagnosed with oesophagus, pancreas and bladder cancer in 
The Netherlands between January 1st 2000 and December 31st 2013 were retrieved from the 
Netherlands Cancer Registry (NCR). The NCR contains patient, tumour and (hospital of) 
treatment data of every newly diagnosed cancer patient. Topography and morphology is coded 
according to the International Classification of Diseases for Oncology (ICD-O) and staging 
according to the TNM-classification. Quality of the data is high and completeness is estimated 
to be at least 95% (19, 20). The total number of inhabitants of The Netherlands was 15.9 million 
in 2000 and 16.8 million in 2013 (21).
We included patients with oesophagus tumours including cardia (C15.0-15.9, C16.0), pancreas 
and peri-ampullary tumours (C25.0-25.9, C24.1, C17.0) and bladder tumours (C67.0-67.9). 
Exclusion criteria were: unknown hospital of surgery or diagnosis at obduction. Per tumour 
the total annual surgical volume was calculated per hospital. In the NCR the type of surgery 
was not completely specified before 2005. Different types of surgery could have been coded 
under a non-specified surgical code; patients with the same treatment code could have had 
a pancreatectomy or only local tumour debulking. We accepted this for oesophagus and 
pancreas cancer because local surgical treatment was not common practice then. From 2005 we 
were able to differentiate oesophagus(cardia) resections and pancreatectomies. Local surgical 
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treatment is more common in bladder cancer, therefore the centralisation of cystectomies is 
studied from 2005 onwards. Only the initial treatment (within six months after diagnosis) for 
every new tumour was registered, thereby disregarding cystectomy for an initial non muscle-
invasive tumour that progressed to muscle-invasive disease more than six months after the 
first diagnosis and a salvage cystectomy after radiotherapy. When the initial treatment took 
more than six months to complete, e.g. in case neoadjuvant chemotherapy, the cystectomy was 
registered. 
Analyses
Hospitals were categorized based on the surgery volume per tumour per year: <10, 10-19 
and ≥20. These categories were chosen based on the first minimum annual thresholds of 10 
which later changed to 20. If the year of surgery was unknown the year of incidence was used. 
Timelines with the proportion of patients per hospital category were plotted from 2000-2013 
(cystectomies from 2005-2013) with descriptions of important influencing factors including 
landmark studies, regulation, and guidelines by specialists societies. STATA version 12.0 was 
used for the main analyses. Trendbreak was analysed using Joinpoint Software. Because the 
minimum surgical volume for pancreas and oesophagus cancer was 10 until 2011 and still is 
10 for cystectomies we analysed trendbreak for minimum annual volumes of 10 (including the 
≥10 and ≥20 category).
Results
The study population is presented in Table 1. The high number of patients with bladder cancer 
can be explained by the high numbers of carcinoma in situ. Figure 1 shows an increasing 
number of surgical procedures for oesophagus, pancreas and bladder cancer.
Oesophagus N (%) Pancreas N (%) Bladder N (%)
Total number of  
patients
29399 19630 52763
Sex
Male
Female
21557 (73.3)
7841 26.7)
10474 (53.36)
9156 (46.64)
40820 (77.36)
11943 (22.64)
Stage
0
1
2
3
4
unknown
296 (1.01)
2683 (9.13)
3950 (13.44)
6405 (21.79)
10899 (37.07)
5166 (17.58)
175 (0.89)
1,726 (8.79)
3950 (20.12)
2334 (11.89)
9876 (50.31)
1569 (8.00)
27539 (52.20)
10776 (20.42)
5759 (10.91)
3125 (5.92)
4892 (9.27)
672 (1.27)
Receiving surgery
Yes
No
8037 (27.3)
21362 (72.7)
4747 (24.18)
14883 (75.82)
6362 (12.06)
46401 (87.94)
Table 1: Char-
acteristics of the 
Table 1. Characteristics of the study population of oesophagus and pancreas cancer (2000-
2013) and bladder cancer (2005-2013)
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study population of oesophagus and pancreas cancer (2000
-2013) and bladder cancer (2005-2013).
Oesophagus cancer
Trendbreak analysis for centralization of oesophagus cancer surgery was significant in 2005 
(Figure 2). A strong rise can be seen in the ≥20 category from 2006 onwards. This coincides 
with the execution of a Dutch prospective study from 2000-2004 which was published in 
2009 but reported upon in national fora earlier (11). In response, the minimum threshold for 
oesophageal resections was set on 10 per year by the Healthcare Inspectorate in 2006. Since 
2011 hospitals are required to perform resections for oesophageal cancer at least 20 times a year 
which results in a decreasing proportion of patients treated in a hospital with an average annual 
volume between 10-20. In 2013 93% of the patients were operated in hospitals that performs 20 
or more surgeries per year. 
Pancreas cancer
Until 2011 the minimum annual threshold for pancreas surgery was 10. Centralization occurred 
rapidly after an initial trendbreak in 2006 and further intensified from 2011 onwards (Figure 
3). The group of patients that underwent surgery in a hospital with an annual volume ≥20 grew 
from 2011 to 2012 as a result of new standards set by the ASN and announced regulation by the 
Healthcare Inspectorate. In 2013 almost 90% of the patients was operated in a hospital with a 
yearly volume of 20 or higher. 
Figure 1. Total number of oesophagectomies and pancreatectomies from 2000-2013 and cystectomies from 2005-
2013 in the Netherlands
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Bladder cancer
The Dutch urological society set a minimum annual threshold of 10 cystectomies per hospital 
in 2010. This coincides with the quality of cancer care report from the Dutch Cancer Society 
and two Dutch studies on the effects of volume on outcomes after cystectomy (Figure 4). De 
Vries et al. observed lower postoperative mortality but this difference could not reach statistical 
significance (22). Goossens et al. found that postoperative mortality after cystectomy is 
significantly inversely associated with high-volume providers (23). No significant trendbreak 
was found. A gradual decrease in the <10 category is seen which becomes bigger from 2009 
onwards. A strong increase in centralization to 20 or more surgeries per year can be seen in 
2013. This was probably caused by discussions on the appropriateness of the (low) threshold 
of 10: in January 2015 a minimum number of 20 cystectomies per year per hospital was decide 
upon by the Dutch urological society (24). No minimum volume was as yet enforced by the 
authorities.
Discussion
Our results show that centralization started in the years following the publication of scientific 
evidence from Dutch studies and international reviews. Scientific evidence obviously preludes 
centralization but does not seem sufficient to initiate a widespread effect. Official publication of 
minimum standards by the medical specialists societies intensified centralization, especially in 
the years before and after publication. This can be seen in all three tumour types. Because official 
regulation sometimes initiated the publication of minimum standards by the specialist societies 
and intensified after that, there seemed to be interaction between the two phenomenon’s though 
regulation seems to have more impact. 
Centralization of oesophageal resections started in 2006 and from 2008 onwards more than 
90% of the patients were treated in hospitals with a surgical volume ≥10 per year. A regional 
prospective study in the Netherlands investigated the effects of centralisation of oesophagus 
resections from 2000-2004 (11). Results were shared in national conferences and combined 
with the growing international evidence strongly enforced the centralization of surgery for 
patients with oesophagus cancer. Consequently, in 2006 the Dutch Health Inspectorate set the 
minimum threshold on ten per year and centralization followed rapidly (Figure 2). Whether 
scientific evidence alone has the same effect is questionable when looking at the centralization 
pattern of the other two tumours. While trendbreak analyses for the centralization of pancreatic 
cancer surgery show a significant increase from 2006 onwards, it took until 2009 for more 
than 80% of the patients to be operated in a hospital with an annual volume ≥10. Unlike 
for oesophagectomies, between 2004 and 2011 no officially regulated minimum threshold 
for pancreas surgery existed. The decrease that can be seen in pancreas surgery in hospitals 
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with an annual volume <10 co-occurs with the threat of regulation and the centralization of 
oesophagus surgery. It is likely that professionals saw pancreas surgery as a logical next step 
in centralization. In bladder cancer, the process of centralization started later compared 
to oesophagus and pancreas surgery. A sharp increase in centralization can be seen in 
2009, a year before the Dutch Society for Urology decided on a minimal annual cystectomy 
threshold of 10. Furthermore, a study comprising data from 2000-2008 confirmed the inverse 
relationship between hospital volume and mortality and morbidity in the Netherlands (25). 
Our study had some limitations. The Netherlands Cancer Registry did not always specify 
the type of surgery or hospital of surgery in the period before 2005. Therefore, patients that 
received local tumour debulking instead of extensive surgery can be present in our analyses 
for oesophagus and pancreas cancer. Because these therapies are not the primary treatment 
options we argue that the effect on our analyses is small. Impact of excluding patients that were 
treated in an unknown hospital of surgery is likely to be small, for oesophagus treatment this 
accounted for 14% between 2000-2005. Furthermore, the question can be raised if any surgical 
procedure for oesophagus and pancreas cancer should take place in a high volume hospital 
anyway. Although the standards are based on malignancies, surgery for benign conditions is 
not registered in the NCR which may give an underestimation of the volume of surgeries in 
that organ. Our study focusses on a national level and regional initiatives such as cooperation 
between groups of surgeons can also have influenced centralization. These initiatives may 
have been triggered by scientific evidence or more general agreements between hospitals and 
surgeons.
Our results show that international scientific evidence was not strong enough to convince 
large numbers of physicians to change their daily practice and centralize surgical procedures. 
Arguments against the generalizability to the Dutch healthcare situation were weakened by 
a growing body of evidence and more importantly, national studies with convincing data. 
Regulation did as such not start centralization, but followed scientific evidence and subsequent 
voluntary centralization. Strong national scientific evidence proved to be needed for acceptance 
in the field and in addition, regulation seems necessary to implement widespread centralization. 
In contrast to ‘regular clinical cancer research’ the results of organizational change studies are 
likely to be greeted with more scepticism which hinders acceptance and implementation. Studies 
with solid designs unravelling the mechanisms of organizational aspects and choices (such as 
centralization) are needed for wider acceptance in the field. It seems inevitable that, once a body 
of evidence has been established on organizational change that influences professional practice, 
some form of regulation is needed to ensure widespread implementation.
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 General discussion
The relationship between organizational external peer review and outcomes of multidisciplinary 
cancer care is complex. We investigated the impact of the external peer review programme for 
multidisciplinary cancer care by establishing four main research questions: (1) How can the 
impact of external peer review on quality of care be studied methodologically? (2) What is the 
impact of the programme on the clinical quality of cancer care? (3) What are the experiences 
of stakeholders and what is the perceived value of the programme? (4) What drives quality 
related organizational change in cancer care? Each question is addressed in the papers included 
in this thesis using multiple research methods including a literature review, quantitative and 
qualitative analyses. The research questions are answered below.
How can the impact of external peer review on the quality of care be studied 
methodologically?
The research question was triggered by the fact that two literature reviews on the impact of 
accreditation were not able to make strong claims about the effects of accreditation on the quality 
of care due to methodological shortcomings and variation in the studies that were included in 
the reviews (1, 2). Before studying the effects of external peer review we wanted to have a clear 
view on the methodology needed and what pitfalls to avoid. An extensive literature review was 
conducted on the methodology of previous studies on the impact of external peer review and 
accreditation. Our search strategy resulted in an initial number of 2025 articles, of which 50 
were included in the review after careful screening. The majority of the studies were performed 
cross-sectionally (27 studies) and only answered the question whether there were differences 
between accredited and non-accredited hospitals. A major shortcoming of most of these studies 
is that the differences can be explained by participation in an accreditation programme but 
other internal and external factors might just be as likely. To study the programme impact, 
the added value of the programme needs to be studied. A longitudinal research design is more 
suited and a dose-response relationship (e.g. hospitals in different phases of accreditation) can 
also be used to study added value. 
There was a difference in studying organization-focussed programmes and service-focussed 
programmes. We distinguished between healthcare organizations as a whole (organization-
focussed) and specific medical specialties or diseases (service-focussed). Studies on organization-
focussed programmes tended to study outcome categories such as ‘organization’, ‘quality 
management’ or ‘safety measures’. These categories included several variables, e.g. availability 
of guidelines and protocols, number of readmissions and number of complications. In service-
focussed programmes, the studied outcome categories were more clinical (e.g. survival). It 
seems easier to select specific care-related outcome variables when the programme is directly 
targeting one specific service or disease. A theoretical framework explaining the results can be 
used to link outcome variables to the studied programme (especially in organization-focussed 
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programmes), but we revealed that this is not used frequently. 
A general research framework is proposed based on the items that we analysed in each study 
in our review (see chapter 2). The framework graphically shows what steps should be taken to 
design an evaluation of an external quality assessment programme. While research in this field 
will remain difficult because of the variation in programmes and outcomes, the framework 
can be used to better structure research designs and increase the comparability of studies. 
What is the impact of the external peer review programme on the clinical quality of cancer 
care?
In chapter 3 and 4 we evaluated the impact of the external peer review programme for 
multidisciplinary cancer care by studying multidisciplinary treatment patterns in colorectal 
and breast cancer patients. Colorectal and breast cancer were amongst the first types of cancer 
that required multidisciplinary treatment. We hypothesized that the willingness of a hospital 
to have external peer review and to follow the recommendations from it, is correlated to 
the hospital giving higher quality of cancer treatment measured by the introduction of new 
multidisciplinary therapies (and better survival in our analyses for colorectal cancer patients).
Chapter 3 presents the results of the treatment evaluation of colorectal cancer patients in the 
Netherlands from 1990 until 2010. There were some indications that external peer review 
increased process related quality of care. Participation in the peer review programme and the 
implementation proportion (IP) of recommendations were associated with a higher proportion 
of stage III colon cancer patients that received adjuvant chemotherapy. For rectal cancer the 
implementation of recommendations seemed more relevant as patients diagnosed in hospitals 
with a high IP received preoperative radiotherapy more often. We did not find a difference 
in the percentage of patients receiving preoperative chemoradiation for T4/M0 rectal cancer 
related to participation nor to the implementation of recommendations. No relationship could 
be seen between programme participation and 5-year survival. Our results add extra evidence 
to the suggestions in previous studies that hospital characteristics play a role in regional and 
inter-hospital treatment variation in colorectal cancer (3, 4).
As the results in colorectal cancer patients suggested at least some positive influence attributable 
to the programme we performed a similar study in breast cancer patients (chapter 4). The 
study population consisted of the same hospitals but to gain more insights in possible regional 
(confounding) factors, the different regions were studied separately (and not aggregated 
into one intervention group). Several multidisciplinary treatment patterns were studied: 
the completeness of breast conserving treatment, introduction of the sentinel node biopsy, 
radiotherapy after breast conserving surgery for ductal carcinoma in situ, adjuvant radiotherapy 
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for locally advanced breast cancer (T3/M0 or any T,N2-3/M0), adjuvant chemotherapy for early 
stage breast cancer (T1-2/N+/M0) and neoadjuvant chemotherapy for T4/M0 breast cancer. No 
benefits could be established for breast cancer patients being treated in hospitals participating 
in the programme nor did the extent in which the hospitals implemented the recommendations 
seem to matter. The study highlighted (large) treatment differences between different regions 
in the Netherlands even after national guidelines were introduced. This is in line with previous 
research by van Steenbergen et al. (5). The regional differences found in our study imply that 
locoregional factors exerted a strong impact on the way cancer care is delivered.  We could not 
find consistent evidence of a positive clinical impact in favour of external peer review. 
It is possible that, while the impact on clinical outcomes remains doubtful, there is a positive 
(perceived) impact on other aspects of care that are difficult to measure by using existing 
(clinical) data.
What are the experiences of stakeholders and what is the perceived value of the 
programme?
Interviews were conducted with 31 stakeholders (medical specialists, nurses and management 
representatives) from 15 different hospitals that participated three times in the programme. 
Positive impact on several aspects of care was perceived, most frequently mentioned were 
the internal positioning of cancer care, formation and role of the oncology committee 
and multidisciplinary patient care meetings. Examples of the perceived impact revealed a 
transferral of responsibilities from individual physicians to multidisciplinary teams consisting 
of physicians, nursing and supporting personnel. This lead to prioritization of cancer care, 
improved communication and a central position of cancer care within general hospitals. 
Interestingly, an important goal for participation is the improvement of clinical care while 
the programme focusses more on the organization of cancer care. There are known to be two 
main barriers to effective cancer care coordination; barriers that are a result of ineffective 
team work and barriers that are the result of inadequate resources (6). Our results especially 
showed a perceived programme impact on those barriers resulting from ineffective teamwork. 
Part of the experienced impact could be attributed directly to the programme based on 
recommendations in the final reports. Interviewees were hesitant to attribute a clinical impact 
to the programme alone, as many in- and external factors can be of influence. Concerning 
clinical outcomes, the programme is more likely to have an indirect effect through e.g. better 
organised multidisciplinary patient care meetings or the introduction of cancer care pathways.
Criticism was raised, especially on the repeated organizational focus and missing links with 
clinical care (most outspokenly in the self-review phase). In combination with the (perceived) 
high investments, the acceptance and willingness for external peer review decreased after 
multiple participations.
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What drives quality related organisational change in cancer care?
The results presented in chapters 3, 4 and 5 suggest that, although some positive effects were found 
in colorectal cancer treatment, external peer review was not a major factor in improving cancer 
care quality. In general, it is not well understood what drives (aspects of) quality improvement. 
Therefore, we were interested to see what stimuli are the most effective in changing the cancer 
care organization in hospitals and on a national level. As an example of organization of care 
we studied centralization patterns of surgery for oesophagus, pancreas and bladder cancer in 
the Netherlands and analysed which factors influenced centralization. Centralization of low-
volume and highly-complex surgical procedures is probably the best studied form of quality 
improvement through organizational change. The results in chapter 6 reveal that the first steps 
were initiated by national scientific evidence. Trends towards further centralization just before 
and after regulatory impulses imply that official regulation is likely to play a major role. It can 
be doubted whether scientific evidence alone is sufficient for widespread centralization. For 
example, centralization of pancreas surgery was slower than oesophagus surgery; unlike for 
oesophagectomies, between 2004 and 2011 no official or enforced minimum threshold for 
pancreas surgery existed. This endorses the notion that some form of regulation is required. 
In contrast to ‘regular clinical cancer research’ the results of organizational change studies are 
likely to be greeted with more scepticism as many factors can additionally be of influence. The 
results from  chapter 6  show that it is unlikely to expect widespread organizational change from 
a voluntary, non-regulated programme such as external peer review.
Methodological considerations
The research presented in this thesis was structured according to the research model we 
designed in chapter 2 and contained several additional items adding to its scientific rigor. We 
studied the added value by using a longitudinal design and a dose-response relationship based 
on the implementation proportion of recommendations from the programme. As we studied a 
homogeneous study population (colorectal and breast cancer patients) and a service focussed 
programme we used clinical outcome indicators. Because all hospitals in the intervention 
regions participated in the programme (even though three did not give permission to use their 
data), there was no programme participation bias. Hospitals that did not participate in the 
programme (because the programme was not available in their regions in our study period) 
were used to create a control group. This created a quasi-experimental study situation. By 
using the Netherlands Cancer Registry (NCR), non-aggregated data from individual patients 
could be used. Analyses were corrected for possible confounding factors such as gender, age 
at diagnosis, year of diagnosis, average hospital volume of diagnoses and presence of an in-
hospital radiotherapy department. 
The external peer review programme for multidisciplinary cancer care was well documented. Not 
only were the final reports per hospital available, all the data from the self-reviews and provided 
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documents was archived. This provided the opportunity to investigate the implementation of 
recommendations and use it as a proxy of how well a hospital participated instead of only 
comparing participating and non-participating hospitals. On the other hand, the programme 
was not designed with the intention to scientifically analyse its effects. More and quantitative 
data on the (perceived) effects after each review round would have made evaluations easier.
The NCR was the main data source for the studies in chapter 3, 4 and 6. This unique database 
made it possible to perform longitudinal analyses in large patient groups already starting before 
the first round of external peer review. Within the NCR clinical administrative data of every 
newly diagnosed cancer patient in the Netherlands is collected. Topography and morphology 
are coded according to the International Classification of Diseases for Oncology and staging 
according to the TNM-classification. Follow-up of vital status is achieved by linking the registry 
to municipal records. Quality of the data is high and data completeness is estimated to be at 
least 95% (7, 8). We did not have the possibility of correcting for possible confounding factors 
such as comorbidity and patient preference. Hospitals in the control group are likely to have 
introduced changes in their organization too, but we were not aware of similar (peer review) 
programmes that have been used.
While studying the impact on treatment patterns of colorectal and breast cancer patients, the 
external peer review programme was necessarily treated as a ‘black box intervention’. Even 
though we optimised our research design based on our literature review in chapter 2, we still 
look at the intervention in terms of effects and less in how these effects were reached because 
the exact working mechanism is unknown and numerous other factors influence the quality of 
cancer care. Firstly, ‘black box interventions’ comprise the expectation that the intervention will 
help to improve quality of care. Secondly, they involve a set of assumptions about how and why the 
programme will bring change (9). Often, these underlying theories are not revealed but remain 
in the minds of policy makers. On the other hand, it can be argued that a ‘black box’ evaluation 
is not a contradiction in terms and outcomes can be evaluated without an explanation (10). Our 
qualitative study revealed part of the black box. The programme established its effect through 
an impact on several aspects of healthcare. This lead to prioritization of cancer care, improved 
communication and a central position of cancer care within general hospitals. External peer 
review therefore seems to work by stimulating improvement in conditions required for cancer 
care instead of having a direct impact on the delivery of care. 
Advice on the role of external peer review in cancer care
Improving the organization of care seems a justified goal, but it may be questioned whether 
the effort put into it is justified if no quantifiable clinical benefits can be shown. In this thesis, 
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we could not find consistent evidence for a positive impact of the organizational external peer 
review programme on the clinical quality of cancer care. Although some positive effects on 
colorectal cancer treatment were seen, no programme impact could be demonstrated in breast 
cancer treatment. Our qualitative study in chapter 5 found a perceived positive impact on several 
aspects of care, but interviewees were hesitant to contribute (clinical) effects to the programme 
alone. This lack of consistent evidence for clinical quality improvement and the outed criticism 
by stakeholders implies that the external peer review programme for multidisciplinary cancer 
care should not be continued. Concerning the future role of external peer review in cancer care 
there are two options: 
-  Changing the design, focus and execution of the programme and incorporating   
 evidence-based clinical performance indicators
-  Stop using external peer review for quality improvement of cancer care
Changing external peer review in cancer care
While external peer review has problems in proving its added value, more recently introduced 
nationwide outcome registrations in the Netherlands were able to show treatment variation 
and improvement of outcomes over the years (11, 12). In chapter 4 we used outcome indicators 
for breast cancer as they are used by the National Breast Cancer Audit (NBCA). The NBCA is 
successful in displaying treatment variation and improvements have been made by reducing 
this variation. Even though outcome registries have proven their success, there is criticism on 
the administrative burden and the value of single outcome indicators is debated (13). There are 
two main concerns about the use of outcome registries to improve healthcare quality. Firstly, 
single outcome indicators are often overinterpreted, resulting in judgements on the underlying 
quality of care. External parties in their turn use these judgements for issuing rewards or 
punishment, e.g. reimbursement by healthcare insurance companies. This leads to a situation 
in which pursuing the outcomes will become a goal on its own. The danger is that other non-
measurable aspects of care will be disregarded and that (too) much of a hospitals financial 
resources is directed to relatively small parts of cancer care. 
Secondly, indicators should be a direct reflection of the quality of care and should not be 
collected only to show variation. For example, one of the clinical outcomes indicators of the 
NBCA is direct breast reconstruction after tumour resections (not used in chapter 4). Large 
inter-hospital variation is measured and even though it might seem better to be treated in a 
hospital with a high percentage of direct reconstructions, not much is known about the quality 
of the direct reconstructions. In these cases, inter-hospital variation can also be a marker of 
the difficulty of using outcome indicators (13). Performance variation, which is the difference 
between any given result and the optimal or ideal result, is therefore more important than 
outcome variation to improve quality (14). 
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If there is to be a role for external peer review in the future of cancer care then it should focus 
on bridging the gap between ‘hard’ outcome data and more ‘soft’ aspects of cancer care delivery. 
Peer reviewers can interpret the outcome indicators and refer these outcomes to their findings 
during the site visit as they are more likely to signal any problems in e.g. clinical decision 
making. Peer review should focus on clinical process measures that are based on scientific 
evidence (e.g. guideline adherence) as these are a reflection of the performance of the hospital. 
Chapter 5 shows that there is support for the role of external peer review serving as a bridge 
between ‘hard’ and ‘soft’ data. The interviewees valued the site visits highly and regarded them 
as the most important part of the programme because of the dialogue that occurs with the 
review committee. Together with the mentioned suggestions for improvement this implies 
that stakeholders value an approach that is not overly focussed on standards but with room 
for autonomy and creativity. Such an approach requires a challenging balance of improvement 
dynamics with standardization and assurance, but can be used to prevent the perception of 
external quality assessment programmes as coercive tools of over-standardization (15).
The current emphasis on care pathways can guide future external peer review. This will 
inevitably lead to external peer review programmes focussing on one type of cancer. Each step 
in the care pathway of a cancer patient can be reviewed by using ‘hard’ data and expert review 
by specially trained peers. An additional advantage of a tumour specific programme is that the 
peer review committee can be recruited from experts in that field. 
Amongst our interviewees, the experienced time investment in the review rounds was rather 
high. Treatment variation can be used as a starting point for external peer review to further 
analyse the underlying structures and processes. Existing registries can be used, to reduce the 
workload of external peer review. National cancer registries can be used as well as a hospitals 
own documentation (e.g. patient satisfaction surveys and admission and discharge data). This 
will also increase the possibilities to quantitatively evaluate the impact of the external peer 
review programme on the quality of care. Another option is to identify the ‘outliers’ in existing 
national outcome registries and only invite them for peer review. Reducing the workload is 
likely to increase acceptance for peer review amongst physicians. 
Stopping external peer review for cancer care
If a new role for external peer review can not be realized or if added value can not be demonstrated 
then the system of external peer review should not be continued in general hospital cancer 
care. A similar discussion was held in Denmark where the health minister proposed to stop 
accreditation and phase out their Danish Quality Model in order to improve quality and more 
importantly, reduce bureaucracy. This general accreditation programme has raised the quality 
of healthcare but further improvement through accreditation is not deemed to be likely. The 
model was introduced in 2005 and the decision follows criticism of how much time medical 
specialists spend on documenting care. While the alternative is yet to be described, a less 
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bureaucratic system is envisioned with fewer but ambitious targets and with an emphasis on 
outcomes. Systematic use of data (variation), decision making tools, good governance and 
financial incentives should put the patient in the centre and stimulate the intrinsic motivation 
for quality improvement. 
Implications for future research
The findings in this thesis have implications for researchers and programme makers in external 
peer review. The research framework from chapter 2 can be used to structure future research 
in this field to improve our knowledge on the impact of accreditation and external peer 
review. More uniformity in research methods and avoiding the pitfalls of research on complex 
interventions can create a stronger evidence base for external peer review and accreditation.
We strongly recommend that programme makers and researchers join forces. Programme 
makers should set clear and measurable goals for external peer review. By incorporating clinical 
outcome indicators in the process of external peer review, this will also increase the possibilities 
for studying a programme impact. Collaboration between researchers and programme makers 
is the only way to perform prospective studies. Prospective studies in this field will be a novelty 
and stronger evidence on the impact of external peer review can be obtained. 
One of the main features of external peer review is the use of specially trained peers. An 
important research objective is how the added value of the peer reviewers can be optimized. Do 
specially trained peers have added value on top of a more audit-like method using only clinical 
data? Another interesting research question is whether external peer review should focus on 
minimum standards or desired levels of care. Only incorporating minimal requirements tends 
to set the bar too low. It can be argued that any standard, and its corresponding metrics, should 
be linked to some desired end outcome (16). Setting standards to the desired level of care might 
keep external peer review challenging in the future. 
In chapter 5 we mentioned that we had difficulties in finding management representatives to 
participate in our interviews. An important reason was the high management turnover. Medical 
staff seems to be the steady factor in hospitals but it is likely that continuity in management will 
benefit policy making in cancer care. We did not have enough data to research the impact 
of high management turnover. Future research should investigate the impact of management 
turnover on the organization and quality of care.
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Overall conclusions
- The evidence from previous studies on the impact of external peer review and accreditation is 
hampered by methodological limitations. Future studies can be improved by using our general 
research framework.
- Positive effects were found on the impact of the external peer review programme on 
multidisciplinary treatment of colorectal cancer patients. Participation in the programme was 
associated with a higher chance of receiving adjuvant chemotherapy in colon cancer and a 
higher implementation rate of recommendations was associated with a higher chance of 
receiving preoperative radiotherapy in rectal cancer. No positive impact of the programme on 
breast cancer treatment could be demonstrated, regional factors seemed to exert a stronger 
impact on treatment variation.
- External peer review had a perceived impact on several organizational aspects of care, most 
importantly the internal positioning of cancer care in  a general hospital, formation and role 
of oncology committee and multidisciplinary patient care meetings. A continuing focus on 
organizational requirements frustrates healthcare professionals and decreases acceptance for 
external peer review.
- Some form of regulation is needed for widespread implementation of quality related 
organizational change.
- If there is to be a role for external peer review programmes in cancer care then they should 
focus on bridging the gap between ‘hard’ outcome data and more ‘soft’ aspects of care. External 
peer review can be used to analyse the underlying structures of inter-hospital variation. 
- External peer review in cancer care should be abandoned if no added value can be demonstrated 
on top of national outcome registries.
- Future research should expand the evidence base for external peer review, preferably through 
prospective, (partly) quantitative  and care pathway oriented studies. 
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 Background and aim of the thesis 
During the 1980’s and 90’s, cancer treatment became increasingly multidisciplinary. Adjuvant 
chemotherapy and radiotherapy transferred cancer treatment from a monodisciplinary 
responsibility to that of multiple medical disciplines. To improve the quality of multidisciplinary 
care, eight regional Comprehensive Cancer Organizations were established. They formed 
networks of healthcare professionals and cancer institutes aiming to improve cancer care 
through registry, research, guideline development, knowledge exchange and organizational 
improvement without having a treatment function themselves. In 2011, they fused into the 
Netherlands Comprehensive Cancer Organization (IKNL). Anticipating the increasing 
multidisciplinary character of cancer treatment, the Comprehensive Cancer Organization 
in the North of the Netherlands introduced an external peer review programme in 1994 to 
review the multidisciplinary organization of cancer care in hospitals. It gradually spread over 
the country and was eventually used nationwide. The majority of Dutch hospitals has gone 
through the procedure at least once and in some regions already thrice. The programme initially 
focussed on organizational requirements for multidisciplinary care. Over time, it evolved and 
also paid attention to important (inter)national trends such as centralization, but the primary 
focus remained on the organization of cancer care as a whole (not specific tumour types). 
Even though there is almost 20 years of experience with the external peer review programme 
for multidisciplinary cancer care there is no structured evidence of its effectiveness on quality 
improvement. This is a more general problem for external peer review and accreditation 
programmes worldwide and the lack of conclusive evidence has led to many calls for research 
in this field. The aim of this dissertation was to investigate the impact of the external peer 
review programme for multidisciplinary cancer care on clinical outcomes and organization. 
Four main research questions structured the research in this dissertation: (1) How can the 
impact of external peer review on quality of care be studied methodologically? (2) What is the 
impact of the programme on clinical quality of cancer care? (3) What are the experiences of 
stakeholders and what is the perceived value of the programme? (4) What drives quality related 
organizational change in cancer care? 
How can the impact of external peer review on quality of care be studied 
methodologically?
In Chapter 2 the results of a literature review on methodological aspects from previous studies on 
accreditation and external peer review are presented. Only original research papers that studied 
the impact on the quality of care were included. Out of an initial number of 2025 retrieved 
references, 50 articles were included and analysed by their methodological characteristics. 
Wide variation in methodology was observed and with the strengths and weaknesses of these 
studies we proposed a general research framework. The framework graphically shows what steps 
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should be taken to design an evaluation study of an external quality assessment programme. 
While research in this field will remain difficult because of the variety of programmes and 
outcomes, the framework can be used to better structure research designs and increase the 
comparability of studies. 
What is the impact of the programme on clinical quality of cancer care?
We examined the clinical impact of the external peer review programme for multidisciplinary 
cancer care on colorectal cancer treatment and survival in Chapter 3. Our hypothesis was that 
the willingness of a hospital to have external peer review and to follow the recommendations 
from it, is correlated to the hospital giving higher quality of cancer treatment measured by 
the introduction of new multidisciplinary therapies and survival. Using the Netherlands 
Cancer Registry, 45705 patients with primary colorectal cancer were included from 23 
participating hospitals and 7 controls (1990-2010). Hospitals from the intervention group were 
dichotomized by their Implementation Proportion (IP) of the recommendations from each 
peer review (high IP vs low IP). Patients from intervention hospitals more frequently received 
adjuvant chemotherapy for stage-III colon cancer compared to the controls. T2-3/M0 rectal 
cancer patients from hospitals with a high IP had a higher chance of receiving preoperative 
radiotherapy (OR 1.31, 95% CI 1.11-1.55), patients from hospitals with a low IP had a lower 
chance (OR 0.75, 95% CI 0.63-0.88). There were no differences in the use of preoperative 
chemoradiation for T4/M0 rectal cancer. Survival was unrelated to the phase of the peer review 
programme in which the hospital was at time of diagnosis. Although some positive effects of 
external peer review on cancer care were found, the results needed to be interpreted cautiously 
due to the ambiguity of the outcomes and possible confounding factors.
Chapter 4 described the results of a similar study in breast cancer patients. Again, the 
introduction of multidisciplinary therapies was evaluated. Major difference with the previous 
study was that the hospitals from the two different Comprehensive Cancer Organization 
regions were not aggregated into one intervention group. By studying these regions separately, 
more insights were gained in regional (confounding) factors. Investigated treatment modalities 
were: the completeness of breast conserving therapy, introduction of the sentinel node biopsy, 
radiotherapy after BCS for ductal carcinoma in situ, adjuvant radiotherapy for locally advanced 
breast cancer (T3/M0 or any T/N2-3/M0), adjuvant chemotherapy for early stage breast cancer 
(T1-2/N+/M0) and neoadjuvant chemotherapy for T4/M0 breast cancer. Our results showed 
regional differences and did not reveal benefits in the multidisciplinary treatment of breast 
cancer patients being treated in hospitals participating in the programme nor did the extent 
in which the hospitals implemented the recommendations matter. Regional factors seemed to 
exert a stronger effect on treatment patterns than hospital participation in external peer review.
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What are the experiences of stakeholders and what is the perceived 
value of the programme?
The perceived role and impact of external peer review in the general hospital setting is presented 
in Chapter 5. Semistructured interviews were held with 31 stakeholders (clinicians, oncology 
nurses and managers) from 15 general hospitals that participated in three rounds of peer 
review over a period of 16 years. It could be carefully concluded that the external peer review 
programme for multidisciplinary cancer care in the Netherlands had a perceived positive impact 
on several aspects of cancer care. In general hospitals, it helped in the internal positioning of 
cancer care and improved structures and processes that encourage multidisciplinary teamwork. 
Our findings suggested that, concerning actual clinical care, external peer review had an 
indirect impact by influencing the multidisciplinary patient care meetings, numbers of staff 
etc. Criticism was raised, particularly on the repeated organizational focus and missing links 
with clinical care (most outspokenly in the self-review phase). As a result, the acceptance of the 
programme that primarily focused on organizational requirements decreased after multiple 
participations.
What drives quality related organizational change in cancer care?
External peer review does not seem to be a major factor in improving clinical quality of cancer 
care. We were interested to see what stimuli are the most effective in changing the cancer 
care organization in hospitals and on a national level. In Chapter 6 we studied centralization 
patterns of surgery for oesophagus, pancreas and bladder cancer as an example of quality 
improvement through organizational change. The first steps towards centralization were 
initiated by national scientific evidence. Strong changes in further centralization just before and 
after regulatory impulses implied that official regulation likely played a major role in widespread 
centralization. Centralization of pancreas surgery was slower than oesophagus surgery; unlike 
for oesophagectomies, between 2004 and 2011 no official or enforced minimum threshold for 
pancreas surgery existed. This endorsed the notion that some form of regulation is required. 
In contrast to ‘regular clinical cancer research’ the results of organizational change studies are 
likely to be greeted with more scepticism as many factors can additionally be of influence. Once 
a body of evidence had been established on organizational change that influences professional 
practice, in addition some form of regulation was needed to ensure widespread implementation.
Discussion
Our results suggest that external peer review was not a major factor in improving the quality 
of cancer care. Improving the organization of cancer care seems a justified goal, but it may be 
questioned whether the continuous effort is justified if no quantifiable clinical benefits can be 
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shown over the years. Concerning the future role of external peer review in cancer care we 
suggested two options: 
- Changing the design, focus and execution of the programme and incorporating   
 evidence-based clinical performance indicators
- Stop using external peer review for quality improvement.
If there is to be a role for external peer review in the future of cancer care then it should focus 
on bridging the gap between ‘hard’ outcome data and more ‘soft’ aspects of cancer care delivery. 
Peer reviewers are more likely to signal any problems in e.g. clinical decision making. External 
peer review should focus on clinical process measures that are based on scientific evidence (e.g. 
guideline adherence) as these are a reflection of the performance of the hospital. Care pathways 
can guide future peer review. Each step in the care pathway of a cancer patient can be reviewed 
by using ‘hard’ data and expert review by specially trained peers. This will inevitably lead to 
external peer review programmes focussing on one type of cancer. Treatment variation can be 
used as a starting point for external peer review to further analyse the underlying structures 
and processes. 
If a new role of external peer review can not be realised or if added value can not be established, 
external peer review in cancer care should be stopped. For future research purposes, we strongly 
recommend that programme makers and researchers join forces. Programme makers should 
set clear and measurable goals for external peer review. By incorporating clinical outcome 
indicators in the process of external peer review, this will also increase the possibilities for 
studying a programme impact. Collaboration between researchers and programme makers is 
the only way to perform prospective studies. Prospective studies in this field will be a novelty 
and stronger evidence on the impact of external peer review can be obtained. 
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Achtergrond en doel van het proefschrift
De zorg voor patiënten met kanker werd in de jaren 80 en 90 van de vorige eeuw steeds meer een 
multidisciplinaire verantwoordelijkheid door een toename van gecombineerde behandelingen 
(zoals chirurgie met aanvullende chemotherapie) en grotere aandacht voor de psychosociale 
gevolgen. Om de kwaliteit van de multidisciplinaire kankerzorg te verbeteren werden de Integrale 
Kanker Centra opgericht (IKC’s). Voor de fusie tot een landelijke organisatie in 2011 (Integraal 
Kankercentrum Nederland, IKNL) waren er acht regionale IKC’s. De IKC’s behandelden 
zelf geen patiënten maar vormden netwerken van ziekenhuizen en zorgprofessionals met als 
doel om de zorg te verbeteren door middel van registratie, onderzoek, richtlijnontwikkeling, 
kennisuitwisseling en organisatieverbetering. Een belangrijk programma om de organisatie van 
kankerzorg in ziekenhuizen te verbeteren was het visitatieprogramma voor multidisciplinaire 
kankerzorg. Dit programma werd in 1994 geïntroduceerd door het Integraal Kankercentrum 
Noord en verspreidde zich gestaag over heel Nederland. Een meerderheid van de Nederlandse 
ziekenhuizen heeft ten minste één keer deelgenomen en een groot deel zelfs al drie keer. 
Het visitatieprogramma richtte zich in eerste instantie op de organisatorische vereisten voor 
multidisciplinaire kankerzorg in ziekenhuizen. Door de jaren heen werd het verder ontwikkeld 
en werd er ook aandacht besteed aan belangrijke (inter)nationale thema’s zoals centralisatie en 
zorgpaden. De primaire focus bleef echter op de organisatie van zorg. Ondanks ruim 20 jaar 
ervaring met dit programma was er geen (wetenschappelijk) bewijs voor een daadwerkelijke 
verbetering van de organisatie of kwaliteit van kankerzorg. Dit is een algemeen probleem voor 
alle visitatie- en accreditatieprogramma’s en het gebrek aan bewijs heeft wereldwijd geleid tot 
een grote vraag naar studies naar de effecten van dit soort programma’s.
Het doel van dit proefschrift was om de impact van het visitatieprogramma voor 
multidisciplinaire kankerzorg op de organisatie van zorg en klinische uitkomsten te bestuderen. 
Het onderzoek in dit proefschrift is gestructureerd door middel van vier onderzoeksvragen: (1) 
Hoe kan de impact van visitaties op de kwaliteit van zorg methodologisch het best bestudeerd 
worden? (2) Wat is de impact van het programma op de klinische kwaliteit van zorg? (3) Wat 
zijn de ervaringen van zorgprofessionals met het programma? (4) Wat zijn de drijfveren voor 
kwaliteitsverbetering door middel van organisatorische veranderingen in de zorg?  
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Hoe kan de impact van visitaties op de kwaliteit van zorg 
methodologisch het best bestudeerd worden? 
In Hoofdstuk 2 worden de resultaten gepresenteerd van een literatuurreview naar de 
methodologische aspecten van studies naar de impact van visitatie en accreditatie. Het doel 
was om meer inzicht te krijgen in de methodologische sterke en zwakke punten van deze 
studies om een algemeen onderzoeksmodel te maken. Er werd gezocht in de Pubmed/Medline, 
Embase en Web of Science databases. Alle artikelen waarin de impact van een visitatie- of 
accreditatieprogramma op de kwaliteit van zorg werd bestudeerd werden geïncludeerd. 
Deze zoekstrategie leverde 2025 artikelen op waarvan er na uitgebreide screening 50 werden 
geselecteerd voor de definitieve analyse. De resultaten toonden een grote variatie in gebruikte 
methodologie en met de sterke en zwakke punten van deze onderzoeken werd een algemeen 
onderzoeksmodel ontwikkeld. Met dit model kunnen nieuwe studies naar de impact van visitatie- 
of accreditatieprogramma’s worden ontworpen. Onderzoek in dit veld zal methodologisch 
moeilijk blijven vanwege de grote verschillen in programma’s en uitkomstmaten maar het 
onderzoeksmodel kan helpen om toekomstig onderzoek beter te structureren. Dit vergroot de 
betrouwbaarheid van de resultaten en bevordert de vergelijkbaarheid van studies.
Wat is de impact van het visitatieprogramma op de klinische kwaliteit 
van zorg?
De impact van het visitatieprogramma op de behandeling en overleving van patiënten met 
colorectaalcarcinoom is beschreven in Hoofdstuk 3. De hypothese was dat de bereidheid van 
een ziekenhuis om visitatie te ondergaan en de aanbevelingen te implementeren correleert met 
een hogere kwaliteit van kankerzorg, gemeten door de introductie van nieuwe multidisciplinaire 
behandelingen en overleving. Alle patiënten met colon- of rectumcarcinoom uit 23 aan de 
visitaties deelnemende ziekenhuizen uit twee IKC regio’s zijn geïncludeerd (interventiegroep). 
Dit zijn de twee IKC regio’s met de meeste ervaring met het programma (drie visitatierondes). 
Een controlegroep werd samengesteld met patiënten uit zeven ziekenhuizen uit regio’s 
waar het visitatieprogramma niet beschikbaar was in de studieperiode (1990-2010). De 
Nederlandse Kanker Registratie (NKR) leverde patiënt-, tumor- en behandelgegevens. 
De interventieziekenhuizen werden onderverdeeld in twee groepen gebaseerd op de 
implementatiegraad van de aanbevelingen van het programma (hoge implementatiegraad vs. 
lage implementatiegraad). In totaal werden er 45705 patiënten geïncludeerd. Patiënten met 
stadium III coloncarcinoom die behandeld werden in ziekenhuizen die deelnamen aan het 
visitatieprogramma kregen vaker aanvullende chemotherapie ongeacht de implementatiegraad 
van de aanbevelingen. Bij T2/T3 rectumcarcinoom was er wel verschil op basis van de 
implementatiegraad. Patiënten uit ziekenhuizen met een hoge implementatiegraad van de 
aanbevelingen ontvingen vaker aanvullende radiotherapie (OR 1.31, 95% CI 1.11-1.55) in 
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vergelijking met de controlegroep, terwijl in ziekenhuizen met een lage implementatiegraad 
minder vaak aanvullende radiotherapie werd gegeven (OR 0.75, 95% CI 0.63-0.88). Er werden 
geen verschillen geobserveerd in de toediening van neoadjuvante chemotherapie voor patiënten 
met T4/M0 rectumcarcinoom. De 5-jaarsoverleving was niet gerelateerd aan de fase van het 
programma waarin het ziekenhuis zich bevond ten tijde van de diagnose. 
Ondanks dat er positieve effecten van visitatie op de behandeling van patiënten met 
colorectaalcarcinoom werden gevonden waren deze niet consistent en moeten de resultaten 
derhalve voorzichtig worden geïnterpreteerd, temeer omdat er mogelijk andere factoren van 
invloed zijn geweest op de uitkomsten.
Hoofdstuk 4 geeft de resultaten weer van een soortgelijke studie onder borstkankerpatiënten. 
Wederom werd de introductie van nieuwe multidisciplinaire behandelingen bestudeerd. Het 
grote verschil met de studie in hoofdstuk 3 is dat de ziekenhuizen uit de twee verschillende IKC 
regio’s niet zijn samengevoegd in één interventiegroep. Door de verschillende regio’s apart te 
bestuderen kon meer inzicht in de regionale variatie worden verkregen. De bestudeerde nieuwe 
behandelingen waren: radiotherapie na borstsparende chirurgie voor ductaal carcinoma in 
situ, adjuvante radiotherapie voor lokaal uitgebreide borstkanker (T3/M0 of elke T/N2-3/M0), 
adjuvante chemotherapie voor vroeg stadium borstkanker (T1-2/N+/M0) en neo-adjuvante 
chemotherapie voor T4/M0 borstkanker. Daarnaast werd de compleetheid van borstsparende 
therapie en de introductie van de schildwachtklierprocedure bestudeerd. In totaal werden 
63516 vrouwelijke borstkankerpatiënten geïncludeerd uit de NKR (1990-2010). De resultaten 
toonden regionale variatie in de behandeling van borstkanker en introductie van nieuwe 
multidisciplinaire therapieën. Een positief effect van het meedoen aan het visitatieprogramma of 
een hoge implementatiegraad van de aanbevelingen kon niet (consistent) worden aangetoond. 
Regionale factoren lijken daarmee een belangrijkere factor voor de gevonden variatie dan 
deelname aan het visitatieprogramma.
Wat zijn de ervaringen van zorgprofessionals met het 
visitatieprogramma?
De ervaren rol en impact van het programma worden beschreven in Hoofdstuk 5. Semi-
gestructureerde interviews werden gehouden met 31 professionals (artsen, verpleegkundigen 
en managers) uit 15 verschillende ziekenhuizen die elk drie keer deelnamen aan het 
visitatieprogramma. Een positieve impact van het programma werd ervaren op meerdere 
aspecten van de zorg zoals de positionering van kankerzorg in de ziekenhuisorganisatie en het 
verbeteren van structuren en processen die multidisciplinair samenwerken ondersteunen. De 
impact op de klinische kwaliteit van zorg is indirect en wordt bereikt door het beïnvloeden van 
bijvoorbeeld zorgpaden, MDO’s en personeelsbezetting.
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Er was veel kritiek op het programma, met name op de terugkerende organisatorische focus, hoge 
tijdsinvestering en de ontbrekende directe link met klinische zorg (vooral in de zelfevaluatie). 
Het gevolg hiervan is dat de acceptatie voor het programma afneemt na meerdere deelnames en 
een nieuwe deelname door een meerderheid niet zinvol wordt geacht.
Wat zijn de drijfveren voor kwaliteitsverbetering door middel van 
organisatorische veranderingen in de zorg?  
Zoals de resultaten van de voorgaande hoofdstukken laten zien is visitatie geen sterk middel om 
de (klinische) kwaliteit van zorg aanwijsbaar en op lange termijn te verbeteren. In hoofdstuk 
6 werd daarom onderzocht welke stimuli het meest effectief zijn in het bewerkstelligen van 
kwaliteitsverbetering door middel van organisatorische veranderingen. De concentratiepatronen 
van oesophagus-, pancreas- en blaaschirurgie werden bestudeerd. Concentratie van 
laagvolume-hoogcomplexe chirurgie is de best bestudeerde vorm van kwaliteitsverbetering 
door organisatorische verandering. Door de jaren heen hebben talrijke studies aangetoond 
dat een hoger behandelvolume correleert met een hogere kwaliteit van zorg. Tijdlijnen van 
de concentratie van oesophagus-, pancreas- en blaaschirurgie werden geplot en belangrijke 
stimuli (o.a. wetenschappelijk bewijs, richtlijnen, regulatie) hierin weergeven. De eerste stap 
naar concentratie van chirurgie werd gezet na de eerste nationale wetenschappelijke publicaties. 
Sterke toename van concentratie net voor en na officiële handhaving van volumenormen 
impliceert dat regulatie een belangrijke rol speelt. Concentratie van pancreaschirurgie vond 
later plaats dan oesophaguschirugie. In tegenstelling tot oesophagectomieën bestond er tussen 
2004 en 2011 geen officiële volumenorm voor pancreatectomieën. Het belang van officiële 
handhaving wordt hierdoor verder onderstreept. In tegenstelling tot klinisch onderzoek 
worden de resultaten van studies naar organisatorische verandering met meer scepsis 
bekeken. Daarnaast spelen er meerdere professionele en financiële belangen bij drastische 
organisatorische veranderingen. De resultaten in hoofdstuk 6 tonen dat als er eenmaal een basis 
van (nationaal) wetenschappelijk bewijs is gevormd dat aanvullende officiële handhaving nodig 
is voor wijdverspreide implementatie van volumenormen. Daarnaast suggereren de resultaten 
dat een vrijwillig visitatieprogramma zonder aanvullende handhaving waarschijnlijk geen 
drastische organisatorische veranderingen zal kunnen bewerkstelligen.
Discussie
De resultaten in dit proefschrift laten zien dat visitatie geen sterk middel is om de kwaliteit 
van de oncologische zorg in ziekenhuizen aanwijsbaar en op lange termijn te verbeteren. 
Verbeteren van de organisatie van zorg is een doel op zich, maar het mag betwijfeld worden 
of de voortdurende investeringen van tijd en geld te verantwoorden zijn als er geen klinische 
effecten meetbaar zijn. Betreffende de toekomstige rol van visitaties zijn er twee opties:
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- Veranderen van de opzet, focus en uitvoering van het programma en gebruik maken  
 van wetenschappelijk onderbouwde prestatie-indicatoren
- Stoppen met visitaties in de oncologie.
Als er een rol is voor visitatie in de toekomst van de kankerzorg dan moet een programma 
fungeren als brug tussen ‘harde’ klinische uitkomstdata en de ‘zachte’ processen die hier aan ten 
grondslag liggen. Om de voorbereidingstijd te verminderen is het aan te raden gebruik te maken 
van reeds bestaande uitkomstregistraties. Variatie in de geleverde zorg zoals aangetoond in de 
hoofdstukken 3, 4 en 6 kan fungeren als uitgangspunt. De rol van de visitator ligt vervolgens in 
het herkennen van problemen en verbeterpunten in klinische processen zoals bijvoorbeeld de 
totstandkoming van klinische besluiten. De huidige focus op zorgpaden kan gebruikt worden 
om elke stap in het zorgproces van een patiënt te beoordelen. Dit leidt onvermijdelijk tot een 
tumorspecifieke visitatie. Aanvullend voordeel hiervan is de mogelijkheid om experts in elk 
tumorgebied aan te stellen als visitator.
Als een nieuwe rol voor visitaties zoals hierboven beschreven niet gerealiseerd kan worden of 
als een positieve impact hiervan niet kan worden bewezen dan dient visitatie voor oncologische 
zorg gestopt te worden. 
Voor toekomstig onderzoek is het van groot belang dat de ontwikkelaars van visitatieprogramma’s 
samenwerken met onderzoekers. Organisatorische en klinische uitkomstindicatoren moeten 
vooraf worden vastgesteld om het effect van het programma te beoordelen. Samenwerking 
tussen programma ontwikkelaars en onderzoekers is de enige manier om prospectieve studies 
op te zetten. Prospectieve studies zouden een unicum zijn in dit onderzoeksgebied en een 
welkome aanvulling op het huidige wetenschappelijk bewijs.
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9 December 2013: Ergens in een bus tussen Pnomh Penh en Siem Reap, Cambodja:  Na een lange dag reizen 
die begon aan de kust in Sihanoukville en zou eindigen in Siem Reap, dicht bij de tempels van 
Angkor, check ik uit verveling nog maar een keer mijn mail op mijn telefoon. In die gammele 
Cambodjaanse bus lees ik dat mijn eerste artikel geaccepteerd wordt door het British Journal 
of Cancer.                                                                                        
31 December 2013: Luang Prabang, Laos: Op mijn laptop bekijk ik de proofs van het artikel en geef 
nog enkele wijzigingen door. Na 3 jaar is de eerste publicatie dan bijna een feit!
Op reis door Zuidoost-Azië na drie jaar promotieonderzoek werden de eerste resultaten 
van mijn promotietraject tastbaar. Promoveren is op zichzelf ook als een lange reis waarin je 
gaandeweg je rugtas vult met kennis en nieuwe ervaringen. In de afgelopen jaren heb ik veel 
geleerd over onderzoek, schrijven en ook over mijzelf. Een reis als deze maak je nooit alleen en 
graag wil ik al mijn ‘reisgenoten’  bedanken:
In de eerste plaats gaat mijn dank uit naar mijn promotoren: prof. dr. Wim van Harten en 
prof. dr. Sabine Siesling. Beiden wil ik bedanken voor de fijne samenwerking. Ik heb het 
gewaardeerd om vrijgelaten te worden en op de juiste momenten weer een zetje in de goede 
richting te krijgen. Wim, jouw inhoudelijke en wetenschappelijke kennis bleken van grote 
waarde. Je bent analytisch sterk en wist vaak met enkele vragen en adviezen tot de kern te 
komen. Onze afspraken sloot je steevast af met de zin: “Kun je hier verder mee?” en ik ben 
dan ook nooit weggegaan zonder ideeën voor nieuwe analyses of aanpassingen aan een artikel. 
Onlangs ben je in Arnhem aan een nieuwe uitdaging begonnen, ik wens je hierbij alle succes. 
Sabine, of moet ik voor deze keer SaBine schrijven? Je mails lezen soms als een syntax die ik 
door de jaren heen steeds beter heb leren te ontcijferen. Hartelijk dank voor alle adviezen en 
enthousiaste begeleiding. In september werd je hoogleraar op de Universiteit Twente en in je 
oratie liet je je ambitie blijken, ik ben erg benieuwd naar alles wat er nog komen gaat!
Renée Otter, als voormalig directeur van het IKNO was jij de initiator van dit promotietraject, 
daarnaast was jij de grondlegger van het visitatieprogramma dat centraal staat in dit proefschrift. 
Helaas is door de fusie je rol vervaagd maar desondanks wil ik je bedanken voor alle adviezen.
De beoordelingscommissie: prof. dr. A. Boer, prof. dr. P.C. Huijgens, prof. dr. M.J. IJzerman, 
prof. dr. N.S. Klazinga, prof. dr. J.A.M. van der Palen  en Prof. dr. R.A.E.M. Tollenaar, hartelijk 
dank dat jullie mijn manuscript wilden lezen en beoordelen.
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Het IKNL wil ik bedanken voor de mogelijkheid om dit promotietraject af te ronden en de 
ondersteuning die ik hierbij heb mogen ontvangen. Ik bedank alle collega’s, met name van de 
afdeling onderzoek, voor de prettige samenwerking.
In het bijzonder wil ik bedanken dr. Boukje van Dijk, mijn kamergenoot in Groningen. Boukje, 
jij hebt mij veel geleerd over onderzoek, statistiek en STATA. Je bent een rasonderzoeker met 
grote kennis van epidemiologie en statistiek. Van dichtbij heb ik gezien hoe jij je eigen ‘area of 
expertise’ hebt opgebouwd en hierin ook steeds zelfbewuster werd. De zorg mag zich in haar 
handen knijpen met onderzoekers zoals jij!
Graag wil ik alle registratiemedewerkers bedanken die dagelijks in de ziekenhuizen in Nederland 
gegevens van kankerpatiënten registeren voor de Nederlandse Kanker Registratie. Jullie werk 
is de basis voor heel veel wetenschappelijk onderzoek en daarmee zo ongelofelijk belangrijk.
Zonder namen te noemen, bedank ik al mijn vrienden die mij in de afgelopen jaren hebben 
gesteund of juist de druk van de ketel haalden. 
Harmen en Berend, in vervlogen tijden koos je je sterkste vrienden als paranimf voor het geval 
de verdediging op een handgemeen uitdraaide. De keuze voor jullie is daarom vanzelfsprekend. 
Van onze studententijd in Groningen naar stapavonden in verre steden als Praag, Skopje, Riga 
en Zagreb tot après-ski in Macedonië. Het is mooi om nu ook op een beschaafde gebeurtenis 
schouder aan schouder te staan.
Mijn familie. Iris, grote zus, ik had je nog bijna ingehaald maar uiteindelijk promoveerde jij 1 
maand eerder dan ik. Je hebt een topprestatie geleverd met het combineren van je promotie en 
je specialisatie tot radioloog. Ik ben supertrots op je.  Jeroen,  alweer bijna 2 jaar samen met Iris 
en ondanks je drukke leven altijd van de partij. Bedankt voor de gezelligheid en je wijnadviezen.
Mijn grote dank gaat uit naar mijn ouders. Papa, mama, dankzij jullie hebben Iris en ik een 
prachtleven waarin we altijd hebben kunnen doen wat we wilden. Jullie hielden ons voor dat 
als je je ergens voor inzet dat je alles kunt bereiken. Wie had gedacht dat dit tot twee promoties 
in een maand zou leiden! Dit proefschrift was er zonder jullie dan ook nooit geweest. Bedankt 
voor jullie onvoorwaardelijke support en liefde.
Schoonouders, schoonzussen en aanhang: bedankt voor de interesse, steun en gezelligheid.
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Lieve Janneke, alles is liefde.                                                                                                                                          
Als coassistenten in Enschede werden we verliefd. Via Groningen zijn we weer terug waar 
alles begon. Ik kan mij geen leven zonder jou voorstellen. Je bent lief, slim en ontzettend 
grappig, hoewel ik dat laatste niet altijd zal toegeven. Ik heb grote bewondering voor de 
bevlogenheid waarmee je jouw werk als SEH-arts KNMG uitvoert. Na mijn promotie mag je 
dan eindelijk los, tijd voor een volgend feestje, gezamenlijk! 
Lieve, lieve Lotte, door jou is al het andere onbelangrijk. Ik verheug mij op alle dingen die gaan 
komen. Je bent mijn alles.
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Melvin Jorrit Kilsdonk was born on September 3rd 1985 in Zwolle, the Netherlands. He attended 
secondary school at the Van der Capellen Scholengemeenschap in Zwolle and received his VWO 
diploma in 2003. The same year he started studying medicine at the University of Groningen. 
During his study, Melvin worked as a kidney perfusionist during outtake and transplantation 
procedures for the European multicentre trial on kidney preservation. After internships at the 
University Medical Centre Groningen and Medisch Spectrum Twente in Enschede he carried 
out his final internship at the department of Ear, Nose and Throat surgery at the University 
Medical Centre St. Radboud, Nijmegen. He wrote his master thesis at the same department on 
patient logistics in head and neck cancer. This triggered his enthusiasm for healthcare policy and 
quality of care. After obtaining his medical degree in 2009 he started working as a registrar in 
ENT surgery at the University Medical Centre Groningen. As this did not bring the fullfillment 
he was looking for, he resigned and began working on the PhD project resulting in this thesis. 
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